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For eukaryotes, DNA is maintained in the form of chromatin, which is comprised 
of millions of repeated nucleosomes. Each nucleosome is assembled by wrapping 147 
base pairs (bp) of DNA around a histone octamer containing 2 copies of H2A, H2B, H3 
and H4. Histone residues undergo a plethora of post-translational modifications (PTM), 
which have a great impact on the conformation and organization of chromatin and 
eventually lead to significant epigenetic changes related to genetic events such as 
transcription, replication and DNA repair.  
SIRT6 and SIRT7 are the newest members of the Sirtuin deacetylase family. 
With a unique NAD+ dependent mechanism, Sirtuin enzymes remove histone lysine 
acetylation and acylations. SIRT6 has been reported as a site-specific histone 
deacetylase targeting H3K9 acetylation (H3K9ac) and H3K56 acetylation (H3K56ac). 
SIRT7 was reported to be specific for H3K18 acetylation (H3K18ac). Compared to other 
Sirtuin members, SIRT6 and SIRT7 exhibit very weak in vitro deacetylation activities on 
acetyl-histones and acetyl-peptides, but become much more active on acetyl-
nucleosomes. However, all previous SIRT6 and SIRT7 histone targets were identified 
using acetyl-peptides as substrates, raising the question whether new active sites could 
be discovered if acetyl-nucleosomes were used as substrates  
The main obstacle to biochemical study on nucleosomal level is the synthesis of 
homogenous nucleosomes with site-specific PTM. In this work, using unnatural amino 




acylation at defined lysine sites, assembled them into acyl- nucleosomes, and screened 
for targets of SIRT6 and SIRT7 with a novel fluorescence-based deacylation assay. As a 
result, we discovered H3 K18 and H3 K27 as the new targets for SIRT6, H3 K36 as the 
new target for SIRT7. The newly identified targets were confirmed in vitro using site-
specific acetyl-nucleosomes, and in vivo using SIRT6 or SIRT7 overexpressed 
mammalian cell model. Using Chip-Seq assay, H3K36ac was discovered to be 
downregulated at specific gene promoters, nucleoli and telomeres. SIRT7 deacetylation 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW  
Epigenetics and Histone Post-translational Modifications (PTM) 
A central question of biology research is to understand the basic rules governing 
evolution and development. Each species maintains a distinct program for the 
development from a single fertilized egg into a complex organism, and this program was 
stored in DNA, which is the primary carrier of genetic information.1 Later, scientists 
start to realize phenotypic differences are not only determined by DNA sequences, but 
also determined by the epigenetic system, which determines how DNA code is 
interpreted.2 For an individual organism, all somatic cells have the same DNA sequence, 
even though they differ a lot in functions and morphologies.3 These differences are 
attributed to changes on epigenetic level, either inherited during reproduction or 
acquired from the environment.4   
DNA is compacted in eukaryotic nucleus as chromatin, the histone-DNA 
complex. Stedman5 proposed histone acted as a general barrier to gene transcription, and 
different cells should have different kinds of histones to modulate gene functions. Hence 
in the early days, histones was regarded as suppressors for DNA transcription and 
activation of gene required total removal of histones from chromatin, until in 1964, when 
Allfrey and Mirsky6 speculated that gene activation was achieved through histone 
acetylation, not complete removal of histone from DNA. Composition of Chromatin was 
determined7 as a string of repeating units of nucleosomes, a 147bp DNA wrapped 
 
2 
histone core containing 2 units of H2A, H2B, H3, and H4 (Figure 2).8 The 2.8 Å 
nucleosome crystal structure9 provided detailed structural information about core 
 




Figure 2 Histone residues (Highlighted) that are found with PTM 
 
histone-DNA interactions and the extended histone N-termini harboring various post-
translational modifications (Figure 2). It is now widely believed that higher order 
structure of chromatin is critical for gene regulation. Inactivated genes tend to form 
highly condensed heterochromatin, while active genes maintain a loose structure called 
euchromatin that is more accessible for transcription machinery.10 Function and 
organization of the chromatin could be modulated through multiple mechanisms, such as 
 
4 
deposition of histone H1 to form higher-order chromatin fibers11, substitution of histone 
variants for canonical histones12, recruitment of histone remodeling complexes to evict 
or deposit histones13, and covalent modification on DNA14 and histones15. Covalent post-
translational modification (PTM) (Figure 1), including methylation on DNA, 
acetylation, methylation, acylation and ubiquitination on histone lysine, methylation on 
arginine, phosphorylation on serine and threonine, could either directly alter DNA-
histone, inter-nucleosome interactions, or serve as platforms to recruit other gene 
function regulators. Recombination of various modifications on different residues, 
together with the genetic information stored in DNA, form an accurate and complicated 
language for cells to precisely carry out gene functions in all kinds of cellular events. 
With the help of new technologies in proteomics and high-throughput sequencing, 
scientists are coming closer to fully understand this ancient but intricate language.  
One of the major obstacles of our endeavor to fully understand epigenetic 
molecular mechanism is the synthesis of histone and nucleosome substrates with post-
translational modification at defined sites. Our understanding of PTM function in vivo 
has been pushed forward by chromatin immunoprecipitation assay combined with high-
throughput gene sequencing,16 however, only correlative conclusion was provided by 
such assay and often the results are confounded by the misread of site-specific PTM 
antibodies.17 On the other hand, the need for histone substrates with designated PTM 
grows, as the development of high-resolution proteomics study has discovered a large 
number of novel histone PTM. The functional and biochemical difference between these 
new PTM with the ‘classical’ PTM such as lysine acetylation and methylation needs to 
 
5 
be elucidated on the histone and nucleosome level.18, 19 If full length histone with 
defined PTM is not available, unmodified residues would be mutated to mimic PTM 
function.20-22 For example, there was an initial hypothesis assuming that lysine 
acetylation exerts its function by neutralizing the positive charge of native lysine, thus 
abolishing the salt bridge interaction between ε-NH2 group and DNA triphosphate 
groups. Loss of DNA-histone interaction leads to destabilization of nucleosome 
structure, which explains the correlation between histone acetylation and active gene 
transcription.23 Based on this hypothesis, lysine to glutamine mutagenesis has been used 
to mimic permanent lysine acetylation, and lysine to arginine mutagenesis has been used 
to mimic permanent unmodified lysine.  Even though researchers have applied this 
strategy to study functions of acetylation both in vivo and in vitro for decades,24-26 doubt 
will still remain before real homogenous acetyl-histone or nucleosome substrates are 
synthesized to confirm K to Q mutation has the same effect with real acetylation. With 
the recent success of synthesizing acetyl-nucleosome, it was found out that glutamine 
was not able to fully mimic acetyl lysine under many circumstances. For example, semi-
synthetic H3K122ac and H3K115ac were refolded into nucleosomes, and these two 
modification were found to induce nucleosome DNA positioning change under thermal 
conditions. Nucleosomes with H3K115Q and H3K122Q mutations were also prepared, 
but these two mimics were not able to demonstrate the same effect with acetyl-
nucleosomes, indicating effects other than electrostatic interactions may exist for lysine 
acetylation.27 The power of the yeast genetics and limited copy number for yeast histone 
genes have enabled in vivo observation of phenotypic change with lysine to glutamine 
 
6 
change.25, 28 Nevertheless, careful interpretation of these results is required because 
acetylation is transient and dynamic in vivo,29 but glutamine and arginine mimic effect 
couldn’t be reversed. In addition, part of acetylation’s function is through the 
recruitment of specific binding protein called bromodomains,30, 31 which couldn’t 
recognize glutamine mimic.  
Alternatively, histones or nucleosomes with defined PTM used to be prepared by 
incubating unmodified substrates with histone modifying enzymes.32, 33 But this 
approach has only narrow application due to the difficulties of purifying recombinant 
epigenetic enzyme, which often exists in forms of large complexes.34-36 Homogenously 
modified histone is hard to prepare using this method since very few of these enzymes 
have single defined target site, most have several target sites with distinct reaction 
efficiency.37-40  Instead of being assembled from recombinant histone, chromatin 
substrates have been isolated from nuclear extract, and directly used for in vitro assay.41-
43  But the results obtained needs to be reconfirmed by other methods since in vivo 
isolated chromatin may contain other preinstalled modifications, which may affect the 
biological functions of the sites being studied.44 Above limitations of traditional 
approaches have prompted chemists to develop convenient and versatile approach to 
synthesize histones with defined PTM both in vitro and in vivo.45 Currently, full length 
histones with defined PTM could be synthesized via the following three strategies--
direct biorthogonal reactions, semi-synthetic strategy and genetic incorporation, and the 
modified histone and nucleosome substrates have been utilized to unravel PTM’s impact 
on chromatin dynamics and to probe epigenetic enzyme functions.46  
 
7 
Methods to synthesize homogenous nucleosomes with defined PTM 
PTM installation through biorthogonal reaction 
Most histones are devoid of cysteines, and the only conserved cysteine in H3 has 
been proved to be inessential for yeast.47 Therefore, after the unique cysteine has been 
mutated to alanine, additional cysteine introduced by site-directed mutagenesis could 
undergo biorthogonal reaction with all kinds of electrophiles to afford PTM mimics. 
Simon et. al. generated mono-, di-, tri-methyllysine analogs (MLA), (H3K9Cme1, 
H3K9Cme2 and H3K9Cme3) through selective alkylations between cysteine at H3K9 
and 2-haloethyl amines (Figure 3). These methyl-lysine analogs have been shown to 
mimic the function of methyl lysine such as binding with effector protein, recognition by 
methyl-lysine antibody, and histone methyltransferase crosstalk.48 Other PTM analogs 
such as acetyl-lysine and methyl-arginine have also been prepared via cysteine 
conjugation strategy.49, 50 
One significant strength of cysteine conjugation is that straight forward 
generation of large quantity of histone sample enabled the structural study of PTMs’ 
effect on chromatin conformation change.51 Also this technique is much easier to handle 
by biologists compared to native chemical ligation and genetic incorporation. However, 
despite the intrinsic drawbacks of the reaction such as slow rate and possible side 
reaction, it still remains doubtful whether these analogs would truly replicate the native 




Figure 3 Methyl-lysine analogs prepared through reaction between cysteine and 2-
haloethyl amines. 
 
lengthen the lysine side chain, and sulfur’s electron withdrawing effect would alter the 
acidity of ε-NH2 group.52, 53 The resulting structural change could potentially affect the 
recognition between methylation analog and effector protein, as is demonstrated in a 
comparison study of chromodomain binding affinity between authentic methyl-peptide 
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and its methyl-lysine analog.54 It is case dependent as to whether KC(me) could fully 
mimic methylation lysine’s binding feature. Caution needs to be taken before using these 
analogs to probe methyl-lysine biological function.  
Recently, Wright et. al.55 utilized biocompatible and biorthogonal free radical 
reaction to site-specifically introduce a wide range of PTM to proteins (Figure 4). Alkyl 
radicals, which were generated through single electron transfer from metals like Zn(0) or 
In(0), readily reacted with dehydroalanine introduced at different positions with varying 
levels of secondary structure, to afford modified residues including methyl-lysine, 
methyl-arginine, phophoryl-serine, and glycosyl-glutamine. Compared to previously 
reported cysteine reaction with alkyl halides, dehydroalanine reaction with carbon 
radical displayed much higher efficiency (complete in less than 30 mins) and larger 
substrate scope. The most significant drawback of this strategy was the lack of 
stereoselectivity, with almost equal amount of D- and L- amino acid generated in the 
process. In this paper, dehydroalanine was generated from cysteine introduced by site-
directed mutagenesis, which is not applicable for protein containing multiple native 
cysteine. To resolve this problem, dehydroalanine could be generated from O-





Figure 4 Using biocompatible and biorthogonal free radical reaction to site-specifically 






Semi-synthetic methods using Native Chemical Ligation and Expressed Protein Ligation 
Histone N-terminal tails extend away from nucleosome core in an unstructured 
conformation, therefore for quite long time, short peptides containing PTM at specific 
site was treated as mimic for studying PTM function in vitro.57-60 After the hallmark 
study of Merrifield to synthesize a fully active 124 residues long ribonuclease A,61 Solid 
phase peptide synthesis (SPPS) enabled facile synthesis of numerous long peptides and 
even small protein.62 The principle of SPPS is to elongate peptide chain on the solid 
support through repetitive cycles of deprotecting α-amine group and coupling of 
protected amino acid to the newly exposed α-amine group. This de novo synthesis 
strategy enabled the site-specific incorporation of various post-translational 
modifications into peptides, including lysine acetylation,63, 64 methylation,65, 66 arginine 
methylation,67 Ser/Thr phosphorylation,68, 69 glycosylation,70 ADP-ribosylation71 and 
ubiquitination.72 Peptides with PTM were utilized to study PTM reader proteins,73 PTM 
modifying enzymes60, 74 and generation of antibodies highly selective for PTM at 
specific site.75, 76 With the discovery of PTM in the histone core, peptide level research 
no longer meet the requirement for epigenetic study, as secondary structures and 
allosteric effects must be considered for PTM study at the globular domain.77 For the N-
terminal PTM, the need for full-length histone and nucleosome substrates also grows as 
additional regulative effects exist beyond the few residues surrounding the PTM being 
studied.78 All histone proteins are over 100 residues long, which are difficult to prepare 
with routine SPPS procedure. This issue was resolved by highly selective peptide 
ligation approach including Native Chemical Ligation (NCL),79 Expressed Protein 
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Ligation (EPL) 80 and Sortase mediated protein ligation.81 To determine which ligation 
strategy to use, location and surrounding residues of the PTM need to be considered.  
To generate full-length histone with PTM on the N-terminal tail, a short peptide 
encompassing modified residues is synthesized by SPPS with α-thioester at the 
carboxylic termini, and the remaining histone fragment is recombinantly expressed with 
an N-terminal cysteine. Then the short peptide and recombinant fragment are connected 
by transesterification, a native peptide bond is later formed via intramolecular S to N 
acyl shift, at the same time leaving a non-native cysteine scar.82 Normally cysteine 
mutation would be introduced at less conserved histone residues away from nucleosome 
core to minimize unwanted functional effect. Otherwise, the cysteine scar could be 
eliminated by desulfurization to afford native alanine residue,83 or modified with 
electrophilic reagent to afford native lysine analog.84 For example, to incorporate single 
or multiple acetylations and methylations on H3 K4 H3 K9, H3 K14, H3 K18, H3 K23 
H4 K5 and H4 K8, alanine to cysteine mutation was introduced at H3 A25 and H4 A15. 
Peptide fragments representing H3 1-24 and H4 1-14 with pre-installed PTMs were 
synthesized by Fmoc/TFA SPPS, and C-terminal fragments representing H3 C25-135 
and H4 C15-102 were recombinantly expressed with an extra N-terminal Met residue, 
which could be autonomously removed before purification. After native chemical 
ligation step, the artificial cysteine residue could be reduced to native alanine by 
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To install modifications onto histone C-terminal tail, a short C-terminal peptide 
capped with cysteine is synthesized by SPPS, and the longer N-fragment is 
recombinantly expressed as an intein-fusion, which is cleaved by thiol reagent to 
generate α-thioesters. Full length histone is then prepared via Native Chemical ligation 
between these two parts. For H3, the native cysteine C110 could be taken advantage for 
the traceless synthesis, PTM could be installed at C-terminal peptide from 109 to 135, 
which is ligated to 1-109 recombinant α-thioester fragment derived from intein-mediated 
splicing (Figure 6).86 For H4, alanine 76 could be mutated to cysteine as ligation site, 
which is later reduced back to alanine to afford the scarless histone.87 
 




For histone modification on the globular domain, sequential ligation strategy is 
required to combine three fragments, which could either be synthesized by SPPS or 
recombinantly expressed.88 To synthesize full length histone H3 with K56 acetylation, 
Shimko et. al. selected native alanine 47 and 91 as the ligation site and mutated them to 
cysteine. The C-terminal fragment (91-135) was synthesized with a free cysteine at A91, 
and regioselectively ligated with the middle fragment (47 -90) with cysteine 47 protected 
as thiazole form, which was deprotected to free cysteine for the second ligation step with 
the N terminal fragment (1-46) (Figure 7).89 Since all three fragment could be 
synthesized by SPPS, similar sequential ligation strategy could be used to incorporate 
any amount of PTM at random positions.  
To synthesize ubiquitinated histone, one popular strategy requires ubiquitin to be 
converted to α-thioester at C-terminal and undergo native chemical ligation with lysine 
side chain modified with β-thiol amine functional group. Chatterjee et. al. produced 
ubiquitin a-thioester lacking the C-terminal glycine, Gly76, and modified H2AK120 
with a bromoacetic acid and a protected 1, 2 amino thiol reagent, which together acted as 
a surrogate form of Gly76. Ligation between these two parts generated native form of 
H2A ubiquitinated at K120, with the following elimination of the artificial β-thiol 
group.72 To accelerate the procedure, ubiquitin Gly76 was surrogated with a cysteine 
attached to histone lysine side chain. After sequential ligation and desulfurization steps, 
ubiquitinated histone was synthesized with a G76A mutation without obviously changes 





Figure 7 Semi-synthesis of Histone H3K56ac 
 
Despite its power of incorporating multiple PTM simultaneously into histone, the 
widespread of semi-synthetic strategy was limited by the difficulty and low yield of 
synthesizing long peptides. Firstly, rounds of protection and deprotection steps are 
required for the solid peptide synthesis, not only for the α-amino group during peptide 
elongation, but also for side chains such as lysine.91 Lengthening of synthetic route and 
following extra purification processes inevitably bring down the overall yield and 
consume more time. Moreover, at least one cysteine is required for the ligation, there is 




Figure 8 Semi-synthesis of H2AK119-Ubiquitin 
 
modifications encompassing residues from 110 to 135. Native alanines could be mutated 
to cysteines, but extra desulfurization step is required to convert them back. For many 
other cases, the artificial cysteine scar is unable to be removed, and extra control 




































































biological function being studied.22 Low efficiency and yield have hampered the 
application of semi-synthetic strategy for nucleosome structural studies, which demand 
larger amount of samples. 
PTM incorporation with amber suppression technique 
Over the last decade, genetic code expansion has enabled site-specific 
incorporation of numerous unnatural amino acids to proteins.92 One significant 
contribution of this technique is the generation of proteins with PTM or PTM mimic at 
desired position, which are indispensable for PTM function elucidation for enzymes and 
proteins in various biological pathways, especially epigenetics. tRNA and aminoacyl-
tRNA synthetase (aaRS) pair, orthogonal to the host endogenous translational 
machinery, is hijacked for the incorporation of non-canonical amino acid.  A wide range 
of PTM have been either directly incorporated into histones (Figure 9), or derived by 
biorthogonal reaction from pre-installed PTM precursors.93  
Acetyl-lysine  
Genetic incorporation of acetyl-lysine into protein was first enabled by an 
evolved Methanosarcina Barkeri pyrrolysyl-tRNA synthetase (MbPylRS) and its 
cognate amber suppressor MbtRNACUA pair. During the library screening, mutations of 
residues in the binding pocket of MbPylRS tend to favor hydrophobic residues with 
larger size, possibly due to fact that acetyl-lysine is a substructure of pyrrolysine. At the 
same time, 20 mM of nicotinamide was added to cell culture to protect nascent acetyl-
lysine from removal by endogenous lysine deacetylase CobB.94 Subsequently, the same 














































the same time, 20 mM of nicotinamide was added to cell culture to protect nascent 
acetyl-lysine from removal by endogenous lysine deacetylase CobB.94 Subsequently, the 
same system was utilized to incorporate acetyl-lysine to Histone H3 at lysine 56 in the 
middle region, which was a difficult target for native chemical ligation. This protein was 
assembled into nucleosome and discovered to facilitate ‘DNA breathing’ compare to 
unmodified H3,95 which means the partial and temporal disengagement of DNA from 
octamer core, which is called DNA breathing Initial attempt of incorporation of acetyl-
lysine to histone H4 was unsuccessful, which was later confirmed to be caused by codon 
bias and mRNA instability of H4 gene. After codon optimizing and switching to an 
RNAseE mutant BL21 strain, site-specific K16 monoacetylated H4 was prepared with 
the yield of 600ug per liter culture.96 Different strategies have also been applied to 
increase the yield of acetyl-H4, such as increasing H4 solubility by fusing it to H3 gene, 
and using C321.ΔA strain.97 Umehara et. al. evolved the library of Methanosarcina 
mazei PylRS library with a new selection system based on the killing activity of the 
toxic ccdB gene. Selected mutant PylRS, together with its cognate tRNAPyl, displayed 
higher incorporation efficiency for aceyl-lysine than the aforementioned MbPylRS 
system.98  
Acyl-lysine 
Besides acetylation, histone lysine was discovered to be also modified in vivo by 
short-chain acylation. Crotonyl- (CrK), Propionyl- (PrK) and butyryl-lysine (BuK) were 
readily incorporated at histone H3K9 by wildtype MmPylRS/tRNAPyl pair, however, 
tandem MS/MS analysis discovered unmodified lysine at H3 K9 postion, which was 
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confirmed to be deacylated by endogenous CobB.99 Evolution of MmPylRS library 
generated a refined system, leading to successful incorporation of CrK, PrK and BuK to 
histone H4.97 Other newly discovered acylations, including ε‑N‑formyl-100 and ε‑N‑2-
Hydroxyisobutyryl-lysine101 were incorporated by the corresponding evolved 
PylRS/tRNA` pair. Our group recently developed a versatile strategy to generate various 
acylations through chemoselective Staudinger ligation with azidohomoleucine, which 
was site-specifically incorporated by an evolved MmPylRS/tRNA pair (Figure 10). 
Succinyl-lysine was in situ generated on histone and nucleosome, avoiding cumbersome 
steps of PylRS library screening.102 
 
 
Figure 10 A versatile approach to generate lysine acylation in situ through bio-
orthogonal Staudinger Ligation. 
 
Methyllysine 
Due to the little structural difference between lysine and methyl-lysine, direct 
evolution of tRNA synthetase mutant that differentiates between these two was 
unsuccessful. Methyl-lysine analogs were initially prepared by Michael addition 















evolved to site-specifically incorporate phenylselenocysteine, which was transformed 
into dehydroalanine for thiol conjugation.103 Our group optimized this strategy by 
directly incorporating Se-alkylselenocysteine into protein with an engineered 
MmPylRS/tRNAPyl pair. The yield was much higher compared to the incorporation of 
phenyl-selenocysteine.104 Authentic monomethyl-lysine was introduced into Histone H3 
through the incorporation of its Boc protected form Nε-tert-butyloxycarbonyl-Nε-methyl-
L-lysine, an efficient substrate for wildtype MbPylRS. Subsequent treatment of dilute  
TFA afforded monomethylated H3 at K9 position.105 Alloc protected and photocaged  
 
 
Figure 11 Incorporation of photocaged monomethyl-lysine and subsequent UV 
deprotection 
 
monomethyl-lysine have also been incorporated with MmPylRS/tRNAPyl system, and 
mild deprotection condition was used without affecting other residues (Figure 11).106, 107   
As for dimethyl-lysine incorporation, a lengthy synthetic route was designed involving 
an initial step of protecting all the other lysines with Cbz group, followed by 
deprotection of Boc-lysine incorporated at the desired position wildtype PylRS, and 





The harsh reaction condition and challenging protection and deprotection cycle of  
multiple lysine residues have prompted us to design much more concise and cleaner 
synthetic route for dimethyl-lysine incorporation. A precursor of Allysine was 
incorporated by an evolved MmPylRS, and then dimethyl-lysine was generated through 
the reductive amination reaction between the released aldehyde group with dimethyl-
amine (Figure 12).109  
 
 
Figure 12 Incorporation of Allysine precursor and subsequence reductive amination to 
afford dimethyl-lysine 
 
Phosphoserine and phosphothreonine 
To genetically incorporate O-phophoserine (Sep),110 an orthogonal pair tRNASep-
SepRS was engineered from Methanocaldococcus jannaschii (Mj) tRNACys and the 
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mesophilic Methanococcus maripaludis (Mm) Sep-tRNA synthetase (SepRS). 
Anticodon change to CUA and additional C20U mutation, which generated tRNASep , 
retained 40% of its ability to be aminoacylated by Sep compared to original tRNACys. A 
negative selection assay discover that simultaneous expression of tRNASep-SepRS pair 
could not incorporate O-phophoserine into chloramphenicol acetyltransferase in E. coli, 
due to the failure of native elongation factor EF-Tu to recognize Sep-tRNASep. After in 
vivo screening assay of EF-Tu library with randomization of 6 residues in the amino acid 
binding pocket, an active mutant EF-Sep was discovered to enable the incorporation of 
O-phosphoserine, which was confirmed by successful synthesis of myoglobin and 
human MEK1 with site-specific serine phosphorylation. Nevertheless, the efficiency is 
still too low for incorporation of phosphoserine into histone. Lee et. al.111 further 
improve the efficiency by optimizing residues at the binding interface between SepRS 
and tRNASep, and residues on EF-Sep which were in contact with SepRS. The optimized 
SepRS9-tRNASep and EF-Sep21 were expressed in E. coli, and facilitated the 
incorporation of phosphoserine onto histone H3 S10. Milligrams of H3S10ph was 
purified and assembled into nucleosome for the activity test of GCN5. In another 
research, Pirman et. al.112 used an reprogrammed C321.ΔA E. coli strain, in which all 
321 TAG stop codon were mutated to TAA stop codon and release factor RF1 was 
knocked out to enable higher read-through by amino acyl tRNA(CUA). Compared to the 
original system in BL21(DE3), a new combination with previously optimized SeRS9, 
EF-Sep21 and a new tRNASep-A37 mutant was demonstrated to increase the yield of O-
phosphoryl GFP by 9 fold in the C321.ΔA strain. Rogerson et. al. further improve O-
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phosphoserine incorporation efficiency through optimizing the affinity between tRNASep 
CUA anticodon region and SepRS substrate binding pocket. Distinct from previous 
studies, tRNASep library containing randomized nucleotides surrounding CUA anticodon 
was also screened, and best mutant displayed almost 10 times higher activity.113  
To incorporate phosphothreonine, a Salmonella enterica kinase PduX was first 
expressed in E. coli to convert threonine to phosphorylated form, and a parallel positive 
selection coupled with deep sequencing discovered a mutant SepRS that favored the 
binding of phosphothreonine over phosphoserine. A plethora of proteins were 
incorporated with phosphothreonine including ubiquitin and CdK2.114  
Phosphotyrosine 
Due to the presence of robust endogenous phosphatases, phosphotyrosine can be 
dephosphorylated in both the free amino acid and protein context. Hence non-
hydrolysable phosphotyrosine analog was initially introduced into protein by genetic 
incorporation.115 p-Carboxymethyl-L-phenylalanine (pCMF), through a M. jannaschii 
tyrosyl tRNA synthetase (MjTyrRS) mutant and the M.jannaschii amber-suppressor 
tyrosyl tRNA (MjtRNATyr
CUA), was incorporated into Tyr701 of STAT1 and found to 
partially mimic the homodimer induction effect of phosphotyrosine-701. Another 
phosphotyrosine analog phosphorimidate was generated by chemoselective Staudinger 
reaction between phosphite and a phenyl-azide group introduced by unnatural amino 
acid incorporation technique, and the resulting modified protein was close enough to be 
recognized by specific phosphotyrosine antibody.116 Two recent publications resolve the 
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difficulty of authentic phosphotyrosine incorporation. Luo et. al. increased the uptake of 
phosphotyrosine by feeding its dipeptide form to E. coli cell culture and the non- 
 
 
Figure 13 Dipeptide from increase bioavailability of phosphotyrosine and its 
nonhydrolyzable mimic 
 
hydrolyzable form 4-phosphomethyl-L-phenylalanine was efficiently incorporated into 
myoglobin with the same MjTyrRS/MjtRNATyr
CUA pair evolved for pCMF (Figure 13). 
On the other hand, phophotyrosine didn’t show up at amber codon position until 1mM 
sodium orthovanadate was added, which inhibit endogenous phosphatase for the 
hydrolyzation of newly incorporated phosphotyrsine.117 Hoppeman et. al. evolved the 
MmPylRS library and discovered a NpYRS mutant for the specific incorporation of a 
phosphotyrosine analog containing the phosphoramidate group, which generated 
authentic phosphotyrosine after hydrolyzation at pH 2 for 36 hours. With this strategy 
ubiquitin with Tyr59 phosphorylation was produced and discovered to drastically reduce 
the binding between ubiquintin and E2 ligase (Figure 14).118  
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For site-specific ubiquitination, pyrrolysine analog D-Cys-ε-Lys was 
incorporated into calmodulin with a 1, 2-amino thiol functionality, which could act as 
the anchor for native chemical ligation with ubiquitin (1-76) α-thioester. Final ligated 
 
 
Figure 14 Incorporation of phosphotyrosine analog and subsequent deprotection 
 
protein contained an artificial D-cysteine at the original ubiquitin G77 position.119 
Completely native isopeptide bond between target protein and ubiquitin was constructed 
with the help of genetic incorporation of δ-thiol-L-lysine precursor δ-thiol-Nε-(p-
nitrocarbobenzyloxy)-lysine, which was a substrate for an evolved MbPylRS/tRNAPyl 
pair. After deprotection, the released 1,2-aminothiol chemoselectively reacted with 
ubiqtuin α-thioester to form a ubiquitin dimer. This technique has the potential for 
traceless synthesis of ubiquitinated histone (Figure 15).120  
 
Figure 15 Genetic incorporation of δ-thiol-L-lysine precursor and subsequent chemical 
transformation to afford ubiquitinated protein 
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Biochemical studies with modified nucleosome substrates 
PTM effects on chromatin structure and dynamics 
Besides influencing biological processes through recruiting other non-histone 
proteins, PTMs on histone N-terminals could directly modulate chromatin conformation 
and dynamics by interfering with interactions between DNA, histone tails and octamer 
core,121 which participate in higher order structure formation. Of the four histone tails, 
H4 N-terminal tail region from 14 to 19 is uniquely important in chromatin fiber 
organization.122 H4K16ac, a prevalent modification marking active gene, happens to be 
located at this region.123 Shogren-Knaak et. al.124 synthesized full length histone 
H4K16ac with one artificial R23C mutation using native chemical ligation. N-terminal 
peptide containing K16 acetylation and C-terminal thioester was synthesized by SPPS, 
and ligated with recombinant C-terminal fragment H4 (C23 to 102). Generated mutant 
histone H4 was assembled into 12-mer chromatin arrays, and the one containing  
H4K16ac required much higher concentration of MgCl2 for 30-nm fiber and higher 
chromosomal domain condensation. (Figure 16) At physiological salt concentrations 
histone N-terminal tails were believed to fold back towards nucleosome core, and 
 




constrained by interactions with nucleosomal DNA.125 Acetylation on N-terminal tail 
may potentially weaken DNA-histone tail interaction and render histone tail more 
accessible. Tencer et. al.126 reported that H3K9Ac facilitated binding of ATP-dependent 
remodeler CHD3 to nucleosome by rendering histone tail more accessible. Histone H3 
containing acetylated lysine analog was prepared via cysteine mediated conjugation. H3 
N-terminal tail accessibility was evaluated by measuring reaction rate between 5-
fluorescein-maleimide and cysteine introduced at two different positions on H3 N-
terminal tail, H3 S10 and H3 A21. Acetylation mimetic at H3 K9 resulted increased 
reaction rate at both positions, indicating a more open conformation was adopted by N-
terminal tail.   
Histone residues located at the entry-exit site of nucleosome directly interact with 
nucleotide. PTMs at these sites could potentially interfere DNA breathing.127 H3K56ac 
is one of most studied modification at this region, its level has been correlated with 
transcription regulation,128 DNA repair129 and DNA replication130 Given its numerous 
important biological functions, the exact function and detailed regulation mechanism 
were not clear, until the several recent successful attempts were reported to synthesize 
homogeneous full length protein and nucleosome substrates.87, 95, 131 Lysine 56 is located 
in the middle of H3 sequence, and was a difficult object for chemical ligation strategy. 
Neumann et. al.95 reported production of full length synthesis of K56 acetylated H3 and 
nucleosome using genetic incorporation approach. The effects of H3K56ac on 
nucleosome stability was firstly investigated using a FRET dye labelled substrate, a Cy3 
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donor was installed on the 5’ end of a 147bp nucleosome positioning DNA, the Cy5 
acceptor was conjugated to H2AK119C via thiol-maleimide coupling. No FRET signal 
difference is observed between wildtype nucleosome and H3K56ac nucleosome, 
indicating K56ac had no effect on nucleosome stability. Therefore, single-pair FRET and 
alternating excitation selection techniques were used to detect subtle conformational 
change, and K56ac was found to cause increase in DNA breathing and higher DNA 
accessibility at the entry-exit site (Figure 17). Chromatin fiber formation is also tested 
but no change was observed between wildtype and H3K56ac nucleosome. On the other 
hand, H3K56ac was able to increase remodeling rate by 40%.   
Using mass spectrometry, Lysine acetylation has been discovered on another 
histone H3 residue K64, which is also located around the nucleosome entry-exit 
region.132 H3K64 is in close contact with nucleosomal DNA and acetylation on this site 
may transform nucleosome into a more open conformation by interrupting DNA-histone 
interaction. To investigate its effect on nucleosome stability and remodeling rate, full-
length H3K64ac was prepared using amber suppression technique and assembled into 
nucleosome with DNA labelled at both sites 35bp from 3’ and 5’ end (Figure 17). While 
increasing salt concentration from 0.5 M to 1 M, H3K64ac nucleosome demonstrated 
higher tendency of self-disassembly. H3K64ac nucleosome was shown to be more 
sensitive to chd1, an ATP-dependent chromatin remodeler. In another histone eviction 
assay, chromatin arrays were assembled using unmodified H3, H3K64ac and H3K64R, 
and more H3K64ac was found to exist in the evicted histone fraction compared to 
wildtype and H3K64R mutant. All the above data supports H3K64ac’s connection with  
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active euchromatin, which is further supported by Chip-seq analysis.   
 
 
Figure 17 Histone lysine acetylation and tyrosine phosphorylation at nucleosome 
entry/exit region increase nucleosome DNA breathing by disrupting electrostatic 
interaction between histone and DNA 
 
Acetyl group on the histone octamer surface possibly weakens the electrostatic 
DNA-histone interaction by neutralizing the positive charge on lysine residue, serine or 
threonine phosphorylation, on the other hand, may destabilize DNA-histone interaction 
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to a larger extent by inducing electrostatic repulsion.133  Effect of phosphorylation 
around histone entry-exit site was also evaluated by a full-length H3Y41ph prepared 
through native chemical ligation (Figure 17).134 H3Y41ph was found to significantly 
increase DNA accessibility and DNA unwrapping. Moreover, combined H3K56ac and 
H3Y41ph modifications together increased DNA accessibility over an order of 
magnitude, indicating that synergistic effect was important for modulating nucleosome 
structure.    
In budding yeast, SWI/SNF histone remodeling complex is involved in the 
regulation of a vast number of genes.135 On the other hand, defects caused by loss of 
SWI/SNF function could be reversed by several histone H3/H4 mutations (SIN 
mutation) around the nucleosome dyad region,136 where the Histone-DNA interaction 
was found to be the strongest.137 Mutations or PTM around these region could alter 
nucleosome stability and remodeling motility.138 Increased nucleosome repositioning,139  
higher susceptibility to DNase140 and impaired chromatin folding141 were observed for 
histone SIN mutations. 
H3K115 and H3K122 are located between two SIN motifs, and are positioned to 
have direct electrostatic interaction with DNA backbone, histone mutants H3K115Q and 
H3K122Q mimicking lysine acetylation showed reduced transcription silencing at 
ribosomal DNA and telomeres.142 The precise role of these mutations on nucleosome 
stability and dynamics required the synthesis of H3K115ac and H3K122ac nucleosome 
(Figure 18). Manohar et. al.27 synthesized full length H3K115ac and/or H3K122ac using 
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the expressed protein ligation strategy. Nucleosome competitive reconstitution assays 
showed that H3K115ac and/or H3K122ac reduced the free energy of histone octamer 
binding to DNA. On the other hand, restriction enzyme digestion assay implied that 
accessibility of DNA around nucleosome dyad region is not affected by H3K115ac 
or/and H3K122ac. Thermal shifting experiments were carried out with nucleosome 
assembled with mp2 nucleosome positioning sequence, and nucleosome with H3K122ac 
demonstrated a slower shifting rate compared to unmodified nucleosome. Nucleosome 
stability could also be evaluated with magnetic tweezer experiment,143 in which 
nucleosome array was extended by an external force and disassembly of nucleosome 
particle would change the force required to stretch chromatin array. H3K115ac and 
H3K122ac full length protein were prepared by EPL,87 and the corresponding chromatin 
exhibited higher fraction of histone eviction following magnetic tweezer stretch.  
 H3 T118 was located around the SIN mutation region and T to I mutation caused 
higher nucleosome motility144 and DNA accessibility.136 North et. al.145 synthesized full 
length H3T118ph by expressed protein ligation, and found H3T118 dramatically 
decreased DNA-histone binding, increased SWI/SNF remodeling, and enhanced 
hMSH2-hMSH6 induced nucleosome disassembly (Figure 18).  Besides canonical 
nucleosome particle, H3T118ph protein was also found to induce the formation of two 
alternative histone-DNA complexes, a nucleosome duplex with two DNA molecules 
wrapped around two histone octamers, and an altosome complex that contains one DNA 
molecule wrapped around two histone octamers. In vivo evidence is still missing for 
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these irregular histone-DNA complexes, but possibility is not ruled out that certain 
histone PTM has the potential to completely alter DNA-histone binding mode.86  
 
 
Figure 18 Histone H3K115ac, H3K122ac and H3T118Ph at the nucleosome SIN region 
disrupt DNA Histone interaction around dyad position 
 
The histone octamer surface surrounding H3 K79, has been reported to be 
important for the maintenance of repressive heterochromatin.146 Histone mutations at 
these regions (72 to 83 for H3 and 78 to 81 for H4), are thus called LRS mutations, as 
they caused the loss of silencing of rDNA in the genetic screening.147 Dimethylation or 
trimethylation of H3K79 (H3K79me2/H3K79me3) has been detected in the transcribed 
regions of active genes.148 Lu et. al.51 prepared H3KC79me2 full length histone analog, 
and obtained crystal structure of this methylated nucleosome. Global nucleosome 
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structure was not altered, but the added demethylation on K79 divert the unmodified the 
lysine from the original position interacting with H4 via weak hydrogen bond, to a new 
position completely exposed to solvent, and another hydrophobic pocket made up by H4 
V70 and H3 L82 was partially uncovered. Modified nucleosome surface could 
potentially affect binding of proteins involved in transcription regulation. The PTM on 
other LRS residues, such as H4K77ac and H4K79ac were found to be simultaneously 
acetylated by high-resolution mass fingerprinting.149 Full length histone H4 di-acetylated 
at H4 K77 and H4 K79 was found to increase the DNA accessibility around the 
nucleosome entry-exit site, but didn’t affect overall nucleosome stability.87  
Discovery of epigenetic enzyme functions 
During replication process, newly synthesized histone H3 is pre-acetylated at 
K56 prior to deposition onto DNA.150 Histone chaperones such as CAF-1, Asf-1 and 
Rtt106 play important roles in replication-coupled nucleosome assembly pathway,151 
but the underneath molecular mechanism had remain unclear. With the full length 
H3K56ac protein prepared by genetic incorporation, Andrews et. al.152 demonstrated 
H3K56ac directly affected the binding affinity between histone H3-H4 complex and 
DNA (Figure 19). Thermodynamic parameters were calculated by monitoring the FRET 
signal change between histone H3-H4, histone chaperone NAP-1, H2A-H2B dimer and 
DNA. H3K56ac was discovered to cause a free energy drop of 1.8 kcal/mol for the 
binding between H3-H4 tetramer and DNA. Once the tetramer was deposited onto DNA, 
H3K56ac had no effect on the additional deposition of H2A-H2B dimer. In budding 
yeast, newly synthesized H3-H4 is associated with histone chaperone Asf1 as a 
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heterodimer, which is presented to histone acetyl-transferase Rtt109 for H3 K56 
acetylation.153 The later deposition of H3K56ac-H4 complex to DNA is performed by 
one of the two histone chaperones, CAF-1 or Rtt106. Winkler et. al.154 synthesize full-
length H3K56ac via genetic incorporation approach, and discovered a 2-fold increase of 
binding between CAF-1 and H3K56ac-H4 complex compared to unmodified H3-H4 
complex. Although H3-H4 complex was found to exist in an equilibrium of heterodimer 
and tetramer, binding ratio was constant between Histone and CAF-1 regardless of the 
form of H3-H4 complex. Su et. al.155 produce full-length H3KC56ac analog via the 
cysteine conjugation approach. Binding parameters measured by ITC revealed that 
H3KC56ac resulted in enhanced binding affinity to Rtt106 histone chaperone. Rtt106 
exists as a homodimer and interacts with H3-H4 complex through a two-site binding  





mode, with a similar 1st dissociation constant Kd1 for both K56ac and unmodified H3-
H4 tetramer, but a drastically different second dissociation constant Kd2. NMR study 
confirmed that Rtt106PH domain (residues 68-301), instead of Rtt106DD domain 
(residues 1-67), binding to H3K56ac peptide with twofold higher affinity compared to 
non-acetylated H3K56 peptide. Larger affinity difference (about 20 fold) on H3-H4 
tetramer level may be contributed by the conformational entropy increase of αN  
helix induced by K56ac. 
H3K27 methylation, mediated by PRC2 histone methyltransferase complex, 
plays important roles in repressive transcription regulation and inactive heterochromatin 
maintenance.156 The activity of PRC2 has been reported to be antagonized by a trithorax 
group protein ash1.157 ash1 was also reported to be a histone methyltrasferase, its 
targeted sites seemed promiscuous when peptide resembling histone N-terminal or 
recombinant histone was used as substrates. Multiple sites including H3 K4 and H4 K20 
were all active for ash1 catalytic domain.158, 159 Therefore the exact molecular 
mechanism of how ash1 antagonize PRC remains elusive, because ash1 targeted sites 
included both active and repressive transcription mark.160 Yuan et. al. clarifies ash1’s 
role in regulating PRC2 activity by testing on nucleosomal substrates.161 On chromatin 
level, ash1 showed higher activity compared to free histone substrate, and site-
specifically dimethylate H3 K36. Full length histone analog H3KC36me3 was then 
prepared by cysteine conjugation and assembled into mononucleosome. Pre-installed H3 
K36 methylation mark greatly impair PRC2’s activity on H3 K27. Chip-seq analysis 
further confirm that H3 K27 methylation and H3 K36 methylation were spatially 
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exclusive of each other, supporting the conclusion that antagonizing effect exist between 
methylations on H3 K27 and H3 K36. Another histone methyl-transferase NSD2 also 
demonstrated distinct target sites on nucleosome substrates and histone octamer along.162 
H3 K36 turned out to be the only active site for NSD2 on nucleosome substrate, while 
all four histones underwent varied extent of methylation and H4 K44 was the primary 
target site for histone octamer. Addition of free DNA could also direct NSD2 to 
dimethylate H3 K36 (Figure 20).    
 
Figure 20 Histone methyl-transferase ash1 and NSD2 shows distinct site-specificities on 
peptide, histone octamer and nucleosome. 
 
Histone acetyl-transferase GCN5 is one of the first identified histone modifying 
enzymes,163 and has been reported to play roles in various biological processes. GCN5 
functions in a multi-subunit complex called SAGA and catalyzes the transfer of acetyl 
group from acetyl coenzyme A to the amino group of histone lysine residues.36 In vivo 
evidence suggested H3K14ac accumulated on histone H3 following the appearance of 
H3 S10 phosphorylation on the same N-terminal tail.164 Peptides spanning residue 1-26 
of histone H3 with phosphorylation on serine 10 exhibited 4 to 6 fold higher activity 
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than unmodified peptide when reacted with yeast GCN5 and [3H] acetyl CoA.165 This 
conclusion was further tested with semi-synthetic nucleosome with H3 S10 
phosphorylation. A native chemical ligation strategy was designed to combine an N-
terminal (1-31) S10 phosphorylated peptide fragment and the remaining C-terminal 
T32C mutant fragment to afford histone H3 with S10 phosphorylation, which was later 
used to assemble chromatin array. When reacted with yeast GCN5, phosphorylated 
nucleosome exhibited 2 fold higher initial velocity compared to unmodified nucleosome, 
however, when SAGA complex was incubated with phosphoryl nucleosome, no 
reactivity difference was observed compared to unmodified nucleosome. The failure of 
H3S10 phosphorylated nucleosome to activate SAGA complex indicated antagonizing 
effect may exist in interactions between other members of SAGA complex and 
nucleosome particle.166  
In another research, Li, et. al.167 attempted to characterized the kinetics of GCN5 
chromatin acetylation, and surprisingly found that the resulting initial velocity data did 
not fit the standard Michaelis-Menten model, but rather close to a cooperative model. 
Cooperativity remained when mononucleosome was used as subtrates, but was lost on 
the H3 peptide substrate, indicating the other copy of H3 N-terminal tail in the same 
nucleosome particle was indispensable for the cooperativity. This proposition was later 
confirmed by SAGA kinetic assay on asymmetric nucleosome with one copy of normal 
H3 and another copy of tailless H3, which showed no cooperativity. SAGA catalytic 
core GCN5 was reported to contain bromodomain, which has been reported to anchor 
SAGA complex to hyperacetylated active chromatin region.168 Bromodomain may play a 
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role in the observed cooperativity by facilitate binding of SAGA complex to nucleosome 
via recognizing acetylation mark installed previously. To validate this proposition, 
histone H3 containing homogenous acetylations on four lysine residues K9, K14, K18 
and K23 was synthesized by native chemical ligation, asymmetric nucleosomes with one 
copy of normal H3 and another copy of tetra-acetylated H3 or another copy of 
unacetylable H3 were assembled. Consistent with previous result, tetra-acetylated H3 
exhibited much higher SAGA activity than unacetylable nucleosome, and mutation 
Y413A of GCN5 abolish SAGA’s cooperativity by impairing bromodomain’s binding to 
acetyl-lysine (Figure 21).169 Other than the bromodomain on GCN5, an H3K4me3  
 
 
Figure 21 Lysine acetylation on one histone H3 tail promote GCN5 acetyl-transferase 




binding domain on one of the SAGA complex member Sgf29, was reported to activate 
SAGA activity on H3K4me3 nucleosome, which was synthesized through  Sortase A 
mediated protein ligation. In contrast to bromodomain activation in which acetylation on 
one H3 tail promote acetylation on the other histone H3, H3K4me3 facilitate acetylation 
on the same H3 N-terminal tail with an in cis mechanism.170 
H3K9 trimethylation is a crucial mark for repressive heterochromatin conserved 
through almost all high eukaryotes.171 Heterochromatin 1 (HP1) has been reported to 
specifically recognize H3K9me3 on a peptide level in vitro and its presence on silenced 
chromatin was concomitant with H3K9me3 in vivo to trigger chromatin condensation.172 
For all HP1 isoforms from Schizosaccharomyces pombe to human, a conserved 
chromodomain (CD) and chromoshadow domain (CSD) were connected by a less 
conserved hinge domain.65 Using histone peptides, it was shown that a conserved 
aromatic cage within the CD binds methylated H3 K9 with low affinity but high 
sequence specificity and a preference for the trimethylated states.65 On a nucleosome 
level, domains other than chromodomain were shown to undertake different roles for 
different HP1 isoforms. For Drosophila Hp1a, interaction with methylated nucleosome 
was much lower than binding with corresponding methyl peptide.173 To obtain H3 K9 
methylated nucleosome, unmodified recombinant histone octamer was incubated with 
Su(VAR)3-9, and 85% percent of the retrieved histone H3 had methylation on K9. No 
methylation was found in other Histone sites. Drosophila HP1a turned out to have no 
preference for H3 K9 methylated chromatin over unmodified chromatin, until other 
HP1a associated proteins such as ACF-1 and SU(VAR)3-9 were added, which interact 
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with HP1a CSD domain. ACF-1 and SU(VAR)3-9 all had strong binding affinity with 
chromatin regardless of modification state,174, 175 indicating a model of HP1a function at 
specific gene locus was through the recruitment by other chromatin binding proteins. In 
another study, homogenous H3K9me3 chromatin was generated using EPL.176 Single-
molecule total internal reflection fluorescence microscopy was used to measure the 
binding dynamics between human HP1α and H3K9me3 chromatin. CSD domain of  
 
 





HP1α was found to induce the self-dimerization, which was important to prolong 
HP1α’s retention time on H3K9me3 chromatin. In another study, NMR spectroscopy 
revealed that human HP1β bond with H3K9me3 nucleosome solely through interaction 
between chromodomain and trimethylated lysine.177 CSD domain and linking hinge 
region showed no participation in binding, as no chemical shift was observed for NMR 
spectroscopy. Just like human HP1α, CSD domain of human HP1β could also induce 
self-dimerization. One single mutation on this domain, I161A could impair human HP1β 
dimerization and more importantly the condensation process of nucleosome array178 
Two bridged chromodomains could simultaneously bind to two H3K9me3 modifications 
on the same or two different nucleosomes, which stabilized the heterochromatin 
conformation via dynamic clustering of chromatin fibers (Figure 22).  
During double strand break repair process, 53BP1 is recruited to DNA damage 
site via interaction with nucleosome simultaneously ubiquitinated at H2A K15 and 
H4K20me2.179 Exact molecular basis of the binding was determined by a Cryo-EM 
structure of the complex between a dimer of the tandem Tudor-UDR segment of 53BP1, 
and doubly modified nucleosome, which was assembled using modified histone mimic 
prepared by cysteine alkylation of a histone H4K20C mutant to yield H4KC20me2 and 
chemical ubiquitination of H2A(K15C) mutant to yield H2AK15ub.180 3D structure 
information revealed a cooperative binding mode between nucleosome core, UDR 
domain and ubiquitin. The 53BP1 UDR domain was in contact with both ubiquitin and 
nucleosome particle, with the N-terminal part located near the H2B-H4 cleft, the C-
terminal part interacted with nucleosome H2A-H2B acidic patch, and the aliphatic 
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residues binding to the hydrophobic patch of ubiquitin (Figure 23). Upon UDR binding, 
ubiquitin adopted a rigid conformation in contact with both H2B αC helix and 53BP1 
UDR domain. On the other hand, 53BP1 tudor domain bound with H4KC20me2 in the 
nucleosome-independent manner.  
Bromodomains, which exist in a variety of epigenetic enzymes and complexes, 
are a group of protein modules recognizing acetyl-lysine through a highly conserved 4 α- 
 
 
Figure 23 53BP1 binds to H4K20me2 and H2AK15Ub nucleosome with multiple 
interactions 
 
helices bundle.181 Researches using acetyl peptides as substrates revealed that 
bromodomains bind to acetyl-lysine with relatively low specificity and selectivity.182 On 
a nucleosomal level, bromodomains appeared to interact with acetyl-nucleosome with 
more than just acetyl-lysine mark. Miller et. al.183 synthesized full length histone H3 di-
acetylated on K18/K23 and histone H4 di-acetylated on K5/K8 by native chemical 
ligation. These modified histones were assembled into nucleosomes, and their binding 
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affinity was measured with BRDT fragments containing either the first bromodomain 
BD1, the second bromodomain BD2 or both. Results obtained by ITC and methyl-
TROSY NMR indicated that only BD1 bound with acetyl-nucleosome via a bivalent 
interaction mode, which included interactions surrounding the acetyl-lysine binding 
pocket and additional DNA interactions with basic patches on the bromodomain. 
Besides BRDT-BD1, other bromodomains also demonstrated binding affinities to DNA 
molecules, suggesting that in general recruitment of bromodomain to acetyl-lysine is 
strengthened by extra binding with nucleosomal DNA.  
Gene transcription activity has been associated with distinct combinations of 
PTM.184  Genome-wide studies demonstrated the spatial connection between active gene 
and H3K4 methylation and H3 acetylation.185 But the detailed mechanism of how these 
PTM coordinate gene transcription has largely unknown. To directly study the functional 
relevance between PTM and gene regulation, an in vitro transcription assay was 
developed. Firstly recombinant histone was assembled onto template DNA in which 
multiple copies of 5S rRNA genes flanked transcription binding sequence and TATA 
box. Then transcription factors and histone modifying coactivators were incubated with 
the recombinant chromatin, followed by transcription initiation with nuclear extract 
containing all the other transcription machineries.186 H3K4me3 was reported to act as 
one of the anchor to recruit transcription factor TFIID to gene promoter.187 and it was 
further illustrated in an in vitro transcription assay that chromatin array constructed with 
full-length H3KC4me3 analog displayed 4-fold higher efficiency compared to array with 
unmodified H3. In vitro chromatin immunoprecipitation analysis showed enhanced 
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recruitment of PIC (preinitiation complex) component, such as P53, TAF3, RNAPII and 
TBP around the promoter regions of the chromatin array, which indicated H3K4me3 
activate gene transcription by facilitating PIC formation. Installment of H3K4me3 by 
methyl-transferase SET1 onto active chromatin was later discovered to be synergistically 
facilitated by transcription factor P53 and co-activator P300,188 predominantly through 
direct interaction of SET1-P53 and SET1-P300. A similar assay was also applied to 
reveal H3R42me2a’s (asymmetric arginine dimethylation) activating effect on 
transcription, possibly through weakening of DNA-histone interaction at entry/exit 
site.189  
In vivo presence of  H3K122ac was discovered by mass spec in human and 
bovine histone.190 Tropberger et. al.191 produced H3K122ac antibody, and demonstrated 
by chip-seq analysis that H3K122ac was associated with active gene promoters and 
enhancers. To investigate molecular mechanism for H3K122ac’s transcription activation 
effect, a full-length H3K122ac was synthesized using genetic incorporation and 
assembled into chromatin containing VP16-Gal4 binding site for in vitro transcription 
assay. H3K122R chromatin array was used as control with unacetylable arginine residue. 
When incubated with AcCoA, GAL4-VP16 activator and p300 acetyl-transferase, 
H3K122ac chromatin showed higher transcription efficiency, possibly through 
facilitating GAL4-VP16 binding after increased histone eviction from DNA. P300/CBP 
was identified as the acetyl-transferase responsible for H3K122ac, however, 
recombinant nucleosome was inactive for P300 in vitro, implying other co-activating 




Human genome is packed in the form of chromatin, the histone-DNA complex 
with nucleosome as the basic unit. The accurate interpretation of genome information 
was carried out in the epigenetics system, which involves multiple levels of regulation 
such as DNA and histone modification. To study how histone modifications affect 
chromatin structure and epigenetic enzymes’ activity, a fundamental challenge is to 
synthesize nucleosome substrates site-specifically modified with the PTM. There are 
three major types of nucleosome synthetic methods, direct biorthogonal reactions, semi-
synthetic strategy and genetic incorporation.  
Recent studies using in vitro assembled intact nucleosome substrates has 
revealed many new biochemical discoveries that haven’t been found with PTM modified 
peptides. In this thesis, we studied histone deacylase SIRT6 and SIRT7. Both enzymes 
show very low activity on acetyl or acyl peptide, but are much more active on 
nucleosome substrates. All previous site-specificity work for SIRT6 and SIRT7 were 
conducted on acetyl-peptides, which raise the question whether new deacylation targets 







CHAPTER II  
IDENTIFICATION OF SIRT6 DEACYLATION TARGETS USING ACYL-
NUCLEOSOMES * 
Introduction 
As a founding member of NAD+-dependent histone deacetylases or sirtuins, 
Saccharomyces cerevisiae Sir2 removes lysine acetylation from histones H3 and H4192 
and subsequently impacts genome stability, gene silencing, and yeast lifespan193. There 
are seven Sir2 homologs in mammalian cells, Sirt1-7194. Among mammalian sirtuins, 
Sirt1, Sirt6, and Sirt7 are primarily localized in the nucleus195. Their functions have long 
been considered to remove lysine acetylation from chromatin196. However, unlike Sirt1 
that displays high deacetylation activities toward acetyl-peptide substrates197, both 
Sirt6198 and Sirt7199 remove acetylation sluggishly from acetyl-peptide substrates. A 
recent discovery that Sirt6 has enhanced activities toward fatty acyl-peptide substrates199 
and directly regulates lysine myristoylation of tumor necrosis factor alpha (TNF-α)200 
has led to speculation that Sirt6 serves primarily to remove lysine fatty acylation instead 
of conventional lysine acetylation. However, both knocking down/out201, 202 and 
overexpressing Sirt6203, 204 in cells have shown clear acetylation pattern changes at H3K9 
and H3K56, indicating deacetylation activities of Sirt6 at these two sites. The 
discrepancy between in vitro weak activities of Sirt6 on acetyl-peptide substrates and  
robust deacetylation of H3K9 and H3K56 by Sirt6 in cells may be due to robust 
*Reprinted with permission from “A Chemical Biology Approach to Reveal Sirt6-
targeted Histone H3 Sites in Nucleosomes”, Wang, W. W., Zeng, Y., Wu, B., 
Deiters, A., Liu, W. R. ACS Chem. Biol. 2016. 11(7), 1973-1981. Copyright (2016), 




deacetylation of H3K9 and H3K56 by Sirt6 in cells may be due to additional cellular 
factors that contribute to Sirt6 activation but were missing in in vitro analysis. 
Indeed, a recent report by Cohen et al. showed higher deacetylation activities of 
Sirt6 on nucleosomes assembled from bulk chicken histones than individual bulk 
chicken histones themselves205, implying that the nucleosome structure may activate 
Sirt6. However, how the nucleosome structure contributes to Sirt6 activation is 
complicated by the high heterogeneity of bulk chicken histones used in this study, which 
contain multiple histone isoforms and many modification types and their combinations. 
To understand how Sirt6 recognizes its acetyl-lysine substrates on the nucleosome level 
and how the nucleosome structure activates Sirt6 on molecular details, homogenous 
acetyl-nucleosome substrates are required45, 90, 166, 206 but have not been applied due to 
the formidable difficulty of their synthesis using traditional methods. Despite the 
remaining doubts of Sirt6 biochemistry, mounting evidence has proved critical functions 
of Sirt6 in metabolism, inflammation, and genome stability207, 208. Transgenic mice 
overexpressing Sirt6 have low LDL cholesterol and triglyceride levels, reduced body fat, 
improved glucose tolerance, and long lifespan. However, Sirt6-deficient mice show a 
markedly degenerative phenotype and have short lifespan, hypoglycemia, and defects in 
DNA repair209. Given its role in regulating glycolysis, loss of Sirt6 leads to tumor 
formation independent of oncogene activation.209 This tumor-suppressing role is also 
supported by the fact that Sirt6 is downregulated in several human cancers including 
pancreatic210 and colorectal cancers211. However, other studies also suggest oncogenic 
effects of Sirt6. Expression of Sirt6 has been found associated with poor prognosis and 
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chemosensitivity in patients with non-small cell lung212, breast213, prostate214, and skin 
cancers215. Sirt6 also plays a role in inflammatory pathways, exerting anti-inflammatory 
effects at the transcriptional level and in bone metabolism, culminating low-turnover 
osteopenia in Sirt6-deficient mice216.   
It is obvious that Sirt6 plays a number of roles in cells, markedly contrasting to a 
very few deacetylation targets which have been identified so far. Recently we 
demonstrated that both Sirt1 and Sirt2 don’t have sequence preferentiality when they 
target lysine for its deacetylation.  When assembled in nucleosome, most of native H3 
acetylation sites (≥ 10) can be targeted and efficiently deacetylated. Given its high 
structural similarity with Sirt1 and Sirt2, Sirt6’s selective targeting of certain sites is of a 
surprise. There are many lysine residues in the four histones whose sequence context 
resembles H3K9 and H3K56. Potentially they are Sirt6-targeted deacetylation sites but 
have not yet tested. As for H3K56, it is located at the nucleosome core region. Unlike 
H3K9 that is at the H3 N-terminal tail and flexible when binding Sirt6, the surrounding 
amino acids of H3K56 have rigid structures. Sirt6 recognition of H3K56 must be 
dramatically different from that of H3K9. This aspect needs to be addressed using 
nucleosome substrates that have acetylation specifically installed at H3K9 and H3K56, 
respectively. In the current study, we showed that Sirt6-targeted sites in nucleosome can 
be swiftly screened and studied using nucleosome substrates site-specifically installed 







Figure 24 synthetic route of amino acids 1 and 2276 
 
Synthesis of NƐ-7-octenoyl-L-Lysine 1 and NƐ-9-decenoyl-L-Lysine 2. Boc-Lys-
OMe was synthesized based on our previously reported method. 217 Boc-Lys-OMe (3.43 
g, 13.2 mmol) was dissolved in 40 ml anhydrous CH2Cl2, and the solution was injected 
into a round bottom flask containing 7-octenoic acid (0.94 g, 6.6 mmol) or 9-decenoic 
acid (1.13 g, 6.6 mmol). EDC (3.26 g, 17 mmol) and DMAP (64.8 mg, 0.53 mmol) were 
dissolved in 10 ml anhydrous CH2Cl2, and injected into reaction flask. The mixture was 
stirred at room temperature overnight under nitrogen gas flow. And the resulting 7-
octenoyl and 9-decenoyl Boc-Lys-OMe were purified by silica gel column 
chromatography.  
7-octenoyl and 9-decenoyl Boc-Lys-OMe were then dissolved in 8 ml THF. 2 M 
NaOH aqueous solution (20 ml) was added dropwise over 30 minutes into the reaction 
flasks cooled by ice-water bath. To complete the reaction, the mixtures were stirred in 
ice-water bath for 1 hour and for another two hours at room temperature. Organic 
impurities were firstly washed away with ethyl ether (40 ml twice), then pH of the 
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aqueous phase was adjusted to 3 by adding 3 M HCl. Neutralized products were 
extracted with ethyl acetate (20 ml twice), and washed with water (40 ml twice) and 
dried by anhydrous MgSO4. Dried solutions were concentrated to around 5ml by 
evaporator in vacuo, into which 5 ml of 4 M HCl dioxane solution was added. The 
resulting suspensions were filtered through bucker funnel, and the precipitated products 
were washed with dry acetone and collected as white solids, NƐ-7-octenoyl-L-Lysine 1 
(1.87 g 93% yield for two steps) 1H NMR (300 MHz, d6-DMSO) δ 8.43 (s, 3H,), δ 7.84 
(t, J=4.5 Hz, 1H,), δ 5.68-5.83 (m, 1H), δ 4.87-5.01 (m, 2H), δ 3.8 (s, 1H), δ 2.98 (q, J=6 
Hz, 2H), δ 1.92-2.05 (m, 4H), δ 1.71-1.81 (m, 2H), δ 1.14-1.51 (m, 10H); 13C NMR (75 
MHz, d-DMSO):172.36, 171.40, 139.20, 115.13, 52.23, 38.38, 35.79, 33.61, 29.99, 
29.01, 28.62, 28.46, 26.68, 22.15). NƐ-9-decenoyl-L-Lysine 2 1H NMR (300 MHz, d6-
DMSO) δ 8.46 (s, 3H,), δ 7.86 (t, J=4.5 Hz, 1H,), δ 5.67-5.83 (m, 1H), δ 4.84-5.00 (m, 
2H), δ 3.78 (s, 1H), δ 2.97 (q, J=6 Hz, 2H), δ 1.90-2.05 (m, 4H), δ 1.70-1.81 (m, 2H), δ 
1.12-1.49 (m, 14H); 13C NMR (75 MHz, d-DMSO): 172,42, 171.35, 139.24, 115.07, 
52.23, 38.38, 35.83, 33.60, 29.97, 29.09, 29.04, 28.99, 28.85, 28.67, 25.73, 22.15.  (1.97 






















Screening against mmPylRS mutants for NƐ-7-octenoyl-L-Lysine 
incorporation. Library with active-site mutations of the Methanosarcina mazei PylRS 
gene was constructed by site mutagenesis PCR which has randomization at active site 
residues (Y306NNK, L309NNK, C348NNK, Y/F/W384). NNK (N=A or C or G or T, 
K=G or T). The following pairs of primers were used to generate the mmPylRS gene 
library, pBK-mmPylRS-348NNK-F, ACC ATG CTG AAC TTC NNK CAG ATG GGA 
TCG GGA TGC ACA CGG, pBK-mmPylRS-348NNK-R, AAA CTC TTC GAG GTG 
TTC TTT GCC GTC GGA CTC; pBK-mmPylRS-306-309-NNK-F, CTT GCT CCA 
AAC CTT NNK AAC TAC NNK CGC AAG CTT GAC AGG GCC CTG CCT, pBK-
mmPylRS-306-309-NNK-R, CAT GGG TCT CAG GCA GAA GTT CTT GTC AAC 
CCT. Positive selection: library DNAs were transformed into TOP10 electrocompetent 
cells containing plasmid pY+ to yield a cell library greater than 1×109 cfu, ensuring 
complete coverage of the pRSL library. Cells were plated on minimal agar plates 
containing 12 μg/mL tetracycline (Tet), 25 μg/mL kanamycin (Kan), 102 μg/mL 
chloramphenicol (Cm) and 1 mM NAA. After incubation at 37 °C for 72 h, colonies on 
the plates were collected and pRSL plasmids were extracted. Negative selection: the 
extracted plasmids from the positive selection were transformed into TOP10 
electrocompetent cells containing plasmid pY- and plated on LB agar plates containing 
50 μg/mL Kan, 200 μg/mL ampicillin (Amp), 0.2% arabinose with or w/o 1mM NAA. 
After incubation at 37 °C for 16 h. Survived cells from plates w/o NAA were pooled to 
extract plasmids for further selections. The alternative selections were repeated. Final 
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positive selected colonies grew on LB plates with 102 μg/mL Cm, 25 μg/mL Kan, 12 
μg/mL Tet, and with or w/o 1 mM NAA. 
Incoporation of NƐ-7-octenoyl-L-Lysine into K48 of Ubiquitin. pETDuet vector 
containing C-terminally His-tagged Ubiqtuin (K48 codon was mutated to amber stop 
codon TAG) was co-transformed into E. coli BL21(DE3) with a pEVOL vector 
containing mmPylRS-YASY. Single colony was picked and inoculated in 2YT medium 
(100 ug/ml Ampicillin 34 ug/ml chloramphenicol). When OD reached to 0.6, 0.5 mM 
IPTG, 5 mM Nicotinamide, 0.2% (w/v) L-arabinose and 1 mM NƐ-7-octenoyl-L-Lysine 
were added into cell culture. Cells were harvested 5 hours later (expression at 37 ℃) 
after induction and sonicated in lysis buffer (50 mM sodium phosphate, 250 mM NaCl, 
0.1% tritonX-100, Ph 7.4). Ub48OcK was purified by Ni-NTA affinity resin. (15 mg/L, 
concentration determined by BCA assay) Sample for ESI-MS analysis was prepared by 
dialyzing into 20 mM NH4HCO3 (4℃, pH 7.0) buffer and dried to pellets using the 
Genevac EZ-Bio Evaporator System. Ub48OcK and w.t. Ubiquitin were both incubated 
with 0.2 mM pyrimidine-tetrazine-FITC (1XPBS buffer, Ph 7.4) for 4 hours at room 
temperature. 100% (w/v) TCA were added into reaction buffer (1:4 v:v), and the 
resulting suspensions were centrifuged at 13000g and 4 ℃ for 20 mins (Eppendorf AG 
minispin). The resulting protein pellets were washed with 100% acetone for two times to 
get rid of residual dye. 15 ul 8 M urea buffer (8 M Urea, 20 mM Tris, 500 mM NaCl, pH 
8.0) was added to dissolve protein pellets and samples were subjected to SDS-page gel 
analysis, FITC signals were blotted using ChemiDoc XRS+ system from Bio-Rad, which 
were compared with coomassie blue staining results.  
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Incorporation of NƐ-7-octenoyl-L-Lysine into Histone H3. pETDuet vectors 
encoding mutant His-TEV-H3-C110A were co-transformed with Pevol-mmPylRS-
YASY into E. coli BL21(DE3) strain.  Single colony was picked and inoculated in 2YT 
medium (100 ug/ml Ampicillin 34 ug/ml chloramphenicol) at 37 ℃. When OD reached 
to 0.6, 0.5 mM IPTG, 5 mM Nicotinamide, 0.2% (w/v) L-arabinose and 1 mM NƐ-7-
octenoyl-L-Lysine were added into cell culture. Cells were harvested 10 hours later 
(expression at 37 ℃) after induction and sonicated in lysis buffer (50 mM Tris, 100 mM 
NaCl, 0.1% Triton-X100, pH 8.0). Inclusion bodies were collected and washed 3 times 
with lysis buffer and 3 times with pellet wash buffer (50 mM Tris, 100 mM NaCl, pH 
8.0). 6 M guanidinium chloride buffer (6 M guanidinium chloride, 20 mM Tris, 250 mM 
NaCl, pH 8.0) was then added to dissolve inclusion bodies.  Suspensions were then 
centrifuged. (11000g, 40 min, 4 ℃, Beckman Coulter Allegra X-15R Centrifuge) and 
supernatants were collected and run through Ni-NTA purification under denatured 
condition. Purified Histone H3 mutants were dialyzed into MilliQ water at room 
temperature and dried to pellets by the Genevac EZ-Bio evaporation system, (yield 
ranging from 5 mg/L to 19 mg/L) concentrations were determined by Pierce BCA 
protein assay kit). 
Expression and purification of Gst-Sirt6. Human Sirt6 fragment was cloned 
from PQE-80l-Sirt6 (addgene #13739) into PGEX4t-3 vector with an N-terminal GST-
tag. And the plasmid was transformed into BL21(DE3) strain. Single colony was picked 
and inoculated in LB medium (100 ug/ml ampicillin) at 37 ℃. When OD reached to 0.6, 
cell culture were cooled down in ice-water bath before 0.5 mM IPTG was added. Cell 
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culture was further incubated at 16 ℃ for 20 hours. Cell pellet was then resuspended in 
lysis buffer (25 mM Tris, 250 mM NaCl, 1 mM PMSF, 1 mg/ml lysozyme, 1 mM 
EGTA, 10 mM DTT, pH 7.5). After sonication, cell lysate was centrifuged (11000g, 40 
min, 4 ℃, Beckman Coulter Allegra X-15R Centrifuge) and supernatant was collected 
and run through GST affinity resin at 4℃. Elution was collected and dialyzed into 
loading buffer (25 mM tris, 20 mM NaCl, 2.5% glycerol, 1 mM DTT, pH 7.5), and 
purified by Q sepharose FF column FPLC (Buffer A: 20 mM Tris, 2.5% glycerol, 1 mM 
DTT, pH 8.0, Buffer B: 20 mM tris, 2.5% glycerol, 1 mM DTT, 1 M NaCl, pH 7.5). 
Purified Sirt6 was concentrated using Amicon Ultra-4 Centrifugal Filter Units and 
dialyzed into storage buffer (25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 
1 mM DTT and 20% glycerol pH 8.0) and stored in -80 ℃. (final concentration 15.3 
uM, determined by Pierce BCA protein assay kit) 
Expression of recombinant human histone His-TEV-H2A, His-TEV-H2B, His-
TEV-H3 and His-SUMO-TEV-H4. pETDuet vectors containing Human His-TEV-H2A, 
His-TEV-H2B, His-TEV-H3-C110A or His-SUMO-TEV-H4 were transcformed into E. 
coli. BL21(DE3) strain. Single colonies were picked and inoculated in 2YT medium 
(100 ug/ml Ampicillin 34 ug/ml chloramphenicol) at 37 ℃. When OD reached to 0.6, 
0.5 mM IPTG was added to induce histone expression. Remaining protein purification 
steps were the same with the purification of recombinant mutant Histone H3.   
Assembly of Octenoyl-Histone H3/H4 tetramers. Pellets of His-TEV-H3 
mutants and Histone His-SUMO-TEV-H4 were redissolved in 6 M guanidinium chloride 
buffer (6 M guanidinium chloride, 20 mM Tris, 250 mM NaCl, pH 8.0). Concentrations 
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were determined by UV absorption at 280 nm (Biotek synergy H1 plate reader) and 
coefficients found on Expasy. 37.5 ug His-SUMO-TEV-H4 and 25 ug His-TEV-H3 
(molar ratio=1:1) were added together and diluted using 6 M guanidinium chloride 
buffer so that total protein concentrations were adjusted to 2 ug/ul. His-SUMO-TEV-H4 
and His-TEV-H3 mixtures were dialysed sequentially at 4 ℃ in 2 M NaCl buffer (2 M 
NaCl, 10 mM Tris, 1 mM EDTA, pH 7.5), 1 M NaCl (1 M NaCl, 10 mM Tris, 1mM 
EDTA, Ph 7.5) and 0.25 M NaCl buffer (250 mM NaCl, 10 mM Tris, 1 mM EDTA, pH 
7.5). Suspensions were centrifuged (13000g 10min, Eppendorf AG minispin) at 4 ℃, 
supernatants were collected. Concentrations of His-TEV-H3/His-SUMO-TEV-H4 
tetramers were determined by UV absorption at 280nm (Tetramers were denatured by 
adding Guanidinium Chloride solids).  TEV protease was added into His-TEV-H3/His-
SUMO-H4 tetramer solution at ratio of 1:30 (TEV protease:Histones w/w). After 
incubation at 4 ℃ for 24 hours, TEV digestion was confirmed to be finished by SDS-
PAGE electrophoresis.  
Deacylation assay on Histone H3/H4 tetramers. H3/H4 tetramer concentrations 
were adjusted to 0.8 uM by adding 0.25 M NaCl buffer (250 mM NaCl, 10 mM Tris, 1 
mM EDTA, pH 7.5). NAD+ (1 mM), DTT (1 mM), GST-Sirt6 (0.4 uM) were also added 
to tetramer reaction solutions. For each control assay, all ingredients were the same 
except that 0.25 M NaCl buffer was added instead of GST-Sirt6. All tetramer reactions 
were incubated at 37 ℃ for 3 hours. 10 mM Nicotinamide and 50 mM Tris at pH 8.0 
were added to quench the reaction. 20 mM iodoacetate was added to reaction solutions 
and the solution was incubated at room temperature for additional half an hour to 
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remove DTT, which may interfere with tetrazine-FITC labeling. Then 0.2 mM 
Pyrimidine-Tetrazine-FITC (in 5 mM DMSO stock solution) was added to tetramer 
solutions. The labeling reaction lasted for 8 hours at room temperature. Then TCA 
precipitation was applied to get rid of unreacted Tetrazine dye. Protein pellets were 
redissolved in 8M Urea buffer (8 M Urea, 20 mM Tris, 500 mM NaCl, pH 8.0). 
Deacylation was monitored by directly detect fluorescent H3 bands from SDS-PAGE gel 
(using Biorad Chemidoc XRS+).   
Assembly of site-specific Octenoyl-Nucleosome. His-TEV-H2A and His-TEV-
H2B pellets were redissolved by 6 M Guanidinium Buffer, Concentrations were 
determined by UV absorption at 280 nm (Biotek synergy H1 plate reader) and 
coefficients found on Expasy. Assembly procedure of His-TEV-H2A and His-TEV-H2B 
dimer was the same with His-TEV-H3/His-SUMO-TEV-H4 tetramers except that total 
protein concentration was 4 ug/ul. Mutant H3/H4 tetramers (6.6 uM), H2A/H2B dimer 
(13.2 uM) and 601-147bp DNA (6.6 uM) (PCR product of a pUC19-601 DNA vector) 
were added together. NaCl concentrations were adjusted to 2 M using 5 M NaCl 
solution. Nucleosome was assembled by serial dilution using TE buffer (10 mM Tris, 
1mM EDTA, pH 7.5) based on NEB EpiMark Nucleosome assembly protocol 
(http://www.neb.com/protocols/2012/06/04/epimark-nucleosome-assembly-kit-e5350). 
The initial 20 ul of Histone-DNA mixture was incubated at room temperature for 30 
minutes. Then 7 ul of TE buffer was added to make NaCl concentration to 1.48 M. After 
30, 60 and 90 minutes, 13 ul, 27 ul, and 93 ul TE buffer was added to sequentially dilute 
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NaCl concentration to 0.25 M. After 30 minutes of incubation at room temperature, 
assembly efficiencies were monitored by 5% 1XTBE Native PAGE gel shift assay.  
Deacylation assay on site-specific Octenoyl-Nucleosome. Concentrations of 
Octenoyl-Nucleosomes were adjusted to 0.66 uM by adding 0.25 uM NaCl buffer, 1 mM 
NAD+ and 1 mM DTT. GST-Sirt6 (0.33 uM) was also added to deacylation reaction 
while 0.25 M NaCl buffer was added to control. All nucleosome reactions were 
incubated at 37 ℃ for 3 hours. 10 mM Nicotinamide and 50 mM Tris at pH 8.0 were 
added to quench the reaction. 20 mM iodoacetate was added to reaction solutions and the 
solution was incubated at room temperature for additional half an hour. Then 0.2 mM 
Pyrimidine-Tetrazine-FITC (in 5 mM DMSO stock solution) was added to nucleosome 
solutions. Labeling reactions lasted for 8 hours at room temperature. All reaction 
solutions were directly loaded onto 8% 1X TBE native PAGE gel. Fluorescence strength 
of separated nucleosome bands were directly blotted using Bio-rad Chemidoc XRS+, 
and EtBr staining was applied after fluorescence detection.  
Time-based deacylation assay on K4Oc, K9Oc, K18Oc, K23Oc and K27Oc 
nucleosomes. Octenoyl-Nucleosome reaction solutions were prepared as the following 
recipe (0.66 uM Nucleosome, 0.33 uM GST-Sirt6, 1 mM NAD+, 1 mM DTT, pH 7.5) 
and equally distributed to 4 tubes labeled as 0 hour, 0.5 hour, 1 hour, 2 hour. And the 
reactions were quenched at these different time-points by adding 10 mM Nicotinamide, 
50 mM Tris (pH 8.0) and 20 mM iodoacetate. After incubation at r.t. for 30 mins, 0.2 
mM Pyrimidine-Tetrazine-FITC (in 5 mM DMSO stock solution) was added to 
nucleosome solutions to label all 4 reactions stopped at different times. Fluorescence 
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strength of separated nucleosome bands were directly blotted using Biorad Chemidoc 
XRS+. EtBr staining was done after FITC blot to reveal the total amount of acylated and 
non-acylated nucleosome. Signal strengths were quantified using Biorad Image Lab 
software. Ratios of strengths between FITC signal/EtBr signals were plotted against 
reaction time.    
Sirt6 Deacetylation assay on K9ac, K18ac and K27ac nucleosomes. Site 
specific Acetyl-Nucleosomes were assembled as the same protocol for Octenoyl-
nuclesomes. Deacetylation solution were prepared as the following recipe (0.66 uM 
Nucleosome, 0.33 uM GST-Sirt6, 1 mM NAD+, 1 mM DTT, pH 7.5). Reactions were 
quenched by adding 10 mM Nicotinamide, and were displayed by 5% 1X TBE Native 
PAGE electrophoresis. Nucleosome assemblies were confirmed by EtBr staining and 
nucleosome bands were then directly transferred to PVDF membrane using Bio-rad 
semi-dry transmembrane protocol (Bio-Rad Trans-Blot Turbo transfer system). The 
membrane was coated with 5% fat-free milk (10 mL) for 1 h at room temperature and 
then treated with pan-acetylation antibody from PTM bio-lab (#PTM-101) overnight at 4 
℃ (1:2000, 5 mL). The membrane then was washed by PBST buffer (PBS with 0.1% 
tween-20, 10 mL) on the shaker six times with 10 min intervals. Then the membrane was 
treated with secondary antibody (1: 10000, 5 mL) from Jackson ImmunoResearch at 
room temperature for 1 h. The membrane then was washed by PBST buffer (PBS with 
0.1% tween-20, 10 mL) on the shaker three times with 10 min intervals. And then the 
result was visualized with Pierce ECL ultra-sensitive Western Blotting Substrate 
(#37070). Images were taken by ChemiDoc XRS+ system from Bio-Rad.  
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Sirt6 overexpression in HEK293t cell line and overall deacetylation level 
detection. Human Sirt6 fragment was cloned from PQE-80l-Sirt6 (addgene #13739) into 
pEGFP vector. 8ug pEGFP-Sirt6 or pEGFP empty vector were added to 60mm HEK293t 
cell culture dishes and packed into cell by 20 ul lipofectamine 2000 (#11668027 Thermo 
Fisher Scientific) reagent. Cell medium was changed after 12 hours of incubation. After 
48 hours, more than 70% of HEK293t cells showed fluorescence under Microscope, and 
cells were scraped off the dish and pelleted by centrifuging at 900RPM for 10 minutes at 
4 ℃. Histone extractions was performed based on a modified version of a previous 
protocol203. Cell pellets were re-suspended in lysis buffer containing 10 mM HEPES, 
150 mM NaCl, 0.5% (w/v) NP-40, protease inhibitor cocktail (#P8340-5ML Sigma), 5 
uM TSA, 10 mM Nicotinamide 1 mM DTT and 1mM PMSF. The suspension was 
incubated on ice for 30 minutes, and centrifuged at 14000 RPM for 15 min at 4 ℃. 
Supernatant containing the cytoplasmic components was removed, and histone was 
extracted from the nuclei precipitates by adding 0.2 N HCl and incubating on ice for 30 
minutes. 1 M Tris solution (pH 8.0) was added to neutralize the histone solution, and 
histone concentration was measured by BCA assay and stored in -80 ℃. For western-
blot analysis, 5 ug of nuclear proteins were displayed by SDS-PAGE electrophoresis, 
transferred to PVDF membrane and blotted by site-specific anti-H3K9ac, anti-H3K18ac, 
anti-H3K27ac, anti-H3K23ac, anti-wtH3 (Acetyl-Histone H3 Antibody Sampler Kit 




























































































































Results and Discussion 
 Inspired by the observation made by Lin, Denu, and their coworkers that Sirt6 
has enhanced deacylation activities toward peptide substrates containing a long chain 
fatty acyl-lysine and the observation by Cohen et al. that the nucleosome structure may 
activate Sirt6, we sought to synthesize acyl-H3 proteins with a long chain fatty acyl-
lysine and use them to assemble corresponding acyl-nucleosomes as active substrates for 
Sirt6 targeted site screening. To analyze Sirt6-catalyzed deacylation on these acyl-
nucleosome substrates, we could transfer denatured histones to membranes during SDS-
PAGE western blot analysis with corresponding fatty acyl-lysine detecting antibodies. 
But it is critical for us to directly analyze deacylation levels on acyl-nucleosome 
substrates instead of on acyl-H3 proteins because the dissolution of acyl-nucleosomes 
during assays to acyl-H3 proteins or their tetramers with H4 will jeopardize our analysis 
and provide misleading results about what sites are targeted by Sirt6 at the nucleosome 
level. However, no commercial antibodies for lysine fatty acylation detection are 
available. An alternative analytical approach is to use mass spectrometry (MS). 
However, doing MS analysis on intact nucleosomes is very challenging. To overcome 
this analytical obstacle, we designed a chemical biology approach as illustrated in 
Figure 26. Previously we showed that a tetrazine undergoes inverse electron-demand 
Diels-Alder reaction readily with an aliphatic terminal olefin under physiological 
conditions and at ambient temperature. This reaction is bioorthogonal and has been 
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applied to label proteins with a terminal olefin in live cells218. Given the high structural 
similarity between an aliphatic terminal olefin and an ethyl group, changing the ethyl 
group at the end of the fatty acyl chain to an olefin is not expected to significantly alter 
Sirt6 deacylation activity toward this fatty acyl-lysine in the nucleosome context. 
However, providing this change will allow directly labeling of a corresponding acyl-
nucleosome with a fluorogenic tetrazine dye in a native PAGE gel. The acyl-nucleosome 
in a native PAGE gel can also be stained with ethidium bromide (EtBr) to confirm its 
nucleosomal state. If Sirt6 is active toward this acyl-nucleosome for its deacylation, the 
resulting non-modified nucleosome cannot be labeled with a tetrazine dye but is still  
Figure 26 Probing Sirt6-targeted lysine deacylation sites in nucleosome using a 
chemical biology approach. A terminal olefin-containing fatty acyl-lysine is site-





visible after staining with EtBr. Therefore by comparing tetrazine-based fluorescent 
intensities of the original acyl-nucleosome and its Sirt6-treated counterpart, Sirt6 
deacylation activity toward this acyl-nucleosome can be obtained. In the following 
section, we will describe how we applied this approach to fish out Sirt6-targeted H3 
lysine sites at the nucleosome level. 
The genetic incorporation of Nε-(7-octenoyl)-lysine (OcK). In order to 
genetically incorporate a terminal olefin-containing fatty acyl-lysine into H3, we 
exploited the amber suppression-based noncanonical amino acid mutagenesis approach 
similarly as in the synthesis of acetyl-H3 proteins. Denu et al. showed that Sirt6 has an 
enhanced deacylation activity toward lysine with a fatty acyl chain length of 8-14 
carbons199. Based on this observation, we synthesized two terminal olefin-containing 
fatty acyl-lysines OcK (Figure 27A) and Nε-(9-decenoyl)-lysine (DeK). OcK can be 
dissolved in water up to 2 mM; nonetheless however, DeK is barely soluble. We did not 
synthesize any acyl-lysine with a chain length long than 10 carbons given its insoluble 
tendency in water. Since we typically use 1 mM noncanonical amino acid for expressing 
noncanonical amino acid-containing proteins, OcK is a viable choice. For its 
incorporation, mutant M. mazei pyrrolysyl-tRNA synthetases that selectively charge 
tRNAPyl with OcK were first identified from a pyrrolysyl-tRNA synthetase gene library 
in which codons for four active site residues, Y306, L309, C348, and Y384, of 
pyrrolysyl-tRNA synthetase were randomized. A widely adopted and double-sieved 
selection protocol was applied for the selection. The mutant, together with OcK and 
tRNAPyl, that displays the best amber suppression efficiency in E. coli has mutations as 
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L309A/C348S and is coined as OcKRS. A plasmid pEVOL-OcKRS that contains genes 
coding OcKRS and tRNAPyl was then constructed. Together with another plasmid 
petDuet-UbK48Am that contains a gene coding ubiquitin with an amber mutation at K48 
and a C-terminal 6×His tag, was used to transform E. coli BL21(DE3) cells. Growing the 
transformed cells in LB supplemented with 1 mM OcK afforded the expression of full-
length ubiquitin Ub-K48oc to a level of 15 mg/L. In the absence of OcK, there was only 
a minimal amount of full-length ubiquitin expressed, confirming that OcKRS is specific 
for OcK (Figure 27C). The purified Ub-K48oc was analyzed by electrospray ionization-
MS that gave a molecular weight of 9511.5 Da, agreeing well with the theoretical 
molecular weight at 9511.7 Da (Figure 27D,). To examine whether OcK in Ub-K48oc 
can be selectively labeled with a fluorogenic tetrazine, a previously synthesized tetrazine 
dye FITC-TZ (Figure 27B) was employed. After incubation with 100 μM FITC-TZ for 
2 h, Ub-K48oc exhibited strong fluorescence in a SDS-PAGE gel, which was in striking 
contrast to no detected fluorescence for wild type ubiquitin, confirming selective 
labeling of OcK in a protein by a tetrazine dye (Figure 27E). 
Sirt6 activities on OcK-containing H3-H4 (oc-H3-H4) tetramers. We next 
proceeded to synthesize mono-acylated H3 (oc-H3) proteins with OcK incorporated at 
K4, K9, K14, K18, K23, K27, K36, K56, and K79, respectively. E. coli BL21(DE3) 
cells transformed with pEVOL-OcKRS and a petDuet-H3 vector coding H3 with an 
amber mutation at a designated site were grown in 2YT supplemented with 1 mM OcK 
to produce an Oc-H3 protein. For OcK incorporation at K4-56 of H3 (H3K4-56oc), an 




Figure 27 The genetic incorporation of OcK. (A) Structures of AcK and OcK. (B) A 
diagram to illustrate fluorescent labeling of Ub-K48oc by a fluorogenic tetrazine dye, 
FITC-TZ. (C) The selective incorporation of OcK into ubiquitin at its K48 position. 
BL21(DE3) cells transformed with plasmid pEVOL-OCKRS coding OcKRS and 
tRNAPyl and plasmid petDuet-UbK48Am coding ubiquitin with an amber mutation at 
K48 were grown in LB with or without 1 mM OcK. (D) The Deconvoluted ESI-MS 
spectrum of Ub-K48oc (calculated molecular weight: 9511.7 Da). (E) The selective 
labeling of Ub-K48oc by FITC-TZ. Proteins were incubated with 100 μM FITC-TZ for 2 
h before they were analyzed by SDS-PAGE. The top panel shows the FITC-based 
fluorescent image of the gel and the bottom panel shows the same gel after it was stained 
with Coomassie Blue.276   
 
affinity purification with Ni-NTA resins and subsequent digestion by TEV protease to 
afford intact oc-H3 proteins. For OcK incorporation at K79 of H3 (H3K79oc), a 
truncation product with translation terminated at K79 predominated and therefore a C-
terminal 6×His tag was introduced for easy separation of the full-length H3K79oc from 
its truncation product. Although we cannot remove the C-terminal 6×His tag from 
H3K79oc without leaving a scar, this C-terminal 6×His tag is not expected to affect 
assembling H3K79oc into either a tetramer with H4 or a nucleosome given that the H3 
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C-terminus is not directly involved in interactions with DNA and other histones. All nine 
oc-H3 proteins were expressed and purified to homogeneity (Figure 29A). They were 
then assembled together with H4 to form oc-H3-H4 tetramers. (Figure 28) Activities of 
Sirt6 on these tetramers were then analyzed. We tested Sirt6 activities on oc-H3-H4 
tetramers instead of oc-H3 proteins themselves due to a concern that the 0.5 M arginine 
that is required to solubilize H3 may affect Sirt6 function. After incubating 0.4 μM Sirt6 
with an oc-H3-H4 tetramer (1.6 μM) for 3 h, the treated tetramer was labeled with FITC-
TZ, analyzed by SDS-PAGE, and then fluorescently imaged. The original tetramer 
without Sirt6 treatment was labeled and analyzed by SDS-PAGE in parallel as a control. 
As shown in Figure 29C, there is no significant fluorescent intensity difference on H3 
between Sirt6-treated and untreated samples for all tetramers except the tetramer 
assembled from H3K9oc. H3K9oc does show weaker fluorescence than its untreated 
counterpart, indicating that Sirt6 targets this site for deacylation although the activity is 
still weak. 
 





Figure 29 Sirt6 activities on oc-H3-H4 tetramers. (A) SDS-PAGE analysis of 9 purified 
oc-H3 proteins. (B) The H3-H4 tetramer structure. (C) Sirt6 activities on 9 oc-H3-H4 
tetramers. A tetramer (1.6 μM) was incubated with or without 0.4 μM Sirt6 for 3 h 
before it was labeled with 200 μM FITC-TZ for 3 h and then analyzed by SDS-PAGE.276 
 
Sirt6 activities on OcK-containing nucleosome (oc-nucleosome) substrates. 
We next moved on to assemble oc-nucleosomes from oc-H3 proteins and used them as 
substrates for Sirt6 in hope that the nucleosome structure will significantly activate Sirt6 
so that a clear picture of Sirt6-targeted H3 sites can be revealed. Following a 
standardized protocol developed by Luger et al.219, we integrated all 9 oc-H3 proteins 
into their corresponding oc-nucleosomes. (For full nucleosome gels see Figure 30) A 
wild type nucleosome assembled from an unmodified H3 protein was also made as a 
control. Deacylation activities of Sirt6 on these oc-nucleosome substrates were then 
analyzed. The analysis setup was to incubate an oc-nucleosome (0.66 μM) with 0.33 μM 
Sirt6 for 3 h and then label it with FITC-TZ and to analyze the labeled product in a 
native agarose gel in parallel with the FITC-TZ-labeled original oc-nucleosome (Figure 
 
76 
31). After imaging the gel via FITC fluorescence, the same gel was then stained with 
EtBr and imaged again via EtBr fluorescence. For all 9 assembled oc-nucleosomes, 
incubating with Sirt6 didn’t cause their dissemblance. All oc- nucleosomes with and 
without treatment with Sirt6 and the control nucleosome showed strong EtBr-stained 
DNA bands around 500 bp, agreeing well with what the literature has reported about the 
migration of a mononucleosome in a native PAGE gel.  All nucleosomes have two EtBr-
stained bands, indicating one major and one minor nucleosome conformer. This is also 
an observation reported previously219. After incubating with Sirt6, H3K4oc-, H3K9oc-, 
H3K18oc-, H3K23oc-, and H3K27oc-nucleosomes displayed much lower FITC-labeling 
fluorescence than their original counterparts. H3K9oc- and H3K18oc-nucleosomes 
showed almost no FITC labeling after their reactions with Sirt6, indicating close to total 
removal of the fatty acyl group. However, H3K36oc-, H3K56oc-, and H3K79oc-
nucleosomes that reacted with Sirt6 showed no obvious FITC labeling difference from 
the original untreated nucleosomes. It is apparent that Sirt6 can target H3K4, H3K9, 
H3K18, H3K23, and H3K27 for their deacylation and that the nucleosome core structure 
significantly improves Sirt6’s catalytic activities at these sites. In our in vitro setup, 
H3K56 is obviously not a preferential deacylation site for Sirt6. 
Sequence preferences of Sirt6-targeted lysine sites. To compare catalytic 
deacylation activities of Sirt6 on the five detected H3 sites, we also carried out a time-
based analysis. H3K4oc-, H3K9oc-, H3K18oc-, H3K23oc-, and H3K27oc-nucleosomes 
were incubated with Sirt6, quenched by 10mM Nicotinamide at different times, labeled 




Figure 30 Assembly of wildtype, Octenoylated and Acetylated Nucleosomes.276 
 
Figure 31 Sirt6 activities on oc-nucleosomes. The image in the top left corner shows the 
structure of a nucleosome. For all gel images, the top panel shows the FITC-based 





were then integrated and plotted for comparison. As shown in Figure 32A, Sirt6 has 
similar catalytic efficiency in removing fatty acylation from H3 K9 and H3 K18. After 
H3K9oc- and H3K18oc-nucleosomes (0.66 μM) reacted with 0.33 μM Sirt6 for 2 h, the 
fatty acyl group was quantitatively removed from the two nucleosomes. The deacylation 
activity of Sirt6 on H3 K27 is a little lower than on H3 K9 and H3 K18 but still 
comparable. There was residual fatty acylation left on the tested H3K27oc-nucleosome 
(0.66 μM) after its incubation with Sirt6 (0.33 μM) for 2 h. For the two sites at H3 K4 
and H3 K23, Sirt6 displays similar deacylation activities although Sirt6 activities on 
these two sites are much weaker than on H3 K9, H3 K18, and H3 K27. After H3K4oc- 
and H3K23oc-nucleosomes (0.66 μM) reacted with 0.33 μM Sirt6 for 2 h, a significant 
amount of these two nucleosomes were still fatty acylated. This time-based assay allows 
us to divide Sirt6-targeted H3 lysine sites into two groups with the first group including 
H3 K9, H3 K18, and H3 K27 and the second group including H3 K4 and H3 K23. Sirt6 
preferentially targets the first group for deacylation but is also catalytically active toward 
the second group.  These two groups of Sirt6-targeted lysine sites also have converged 
consensual sequences.  As shown in Figure 32B, H3 K9, H3 K18, and H3 K27 all have 
a preceding arginine residue right at its N-terminal side and there is an N-terminal serine 
or threonine residue followed by H3 K4 and H3 K23. These two concensual N-terminal 
adjacent residues apparently determine catalytic activities of Sirt6 on the five targeted 






Figure 32 SIRT6 site specificity is determined by amino acid sequence. (A) Relative 
catalytic activities of Sirt6 on five oc-nucleosome substrates. An oc-nucleosome 
substrate (0.66 μM) was incubated with 0.33 μM Sirt6. The reaction was stopped at 0.5, 
1, and 2 h and oc-nucleosome samples at these different times were labeled with FITC-
TZ and analyzed in a native agarose gel together with the original oc-nucleosome (0 h). 
Top panels show FITC-based images, middle panels show same gels based on EtBr 
staining, and bottom panels show relative integrated FITC-based fluorescent intensities 
at different reaction times. (B) Sirt6-targeted lysine sites show consensual sequences 
highlighted in red and blue rectangles.276 
 
Sirt6 catalyzes deacetylation at H3 K9, H3 K18 and H3 K27 in cells. With 
knowing that H3 K9, H3 K18, and H3 K27 are preferential Sirt6-targeted sites for 
deacylation, we next move on to demonstrate that Sirt6 indeed catalyzes deacetylation at 
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these three sites in an in vitro biochemistry setup and in cells. Three corresponding 
acetyl-nucleosomes were assembled from H3K9ac, H3K18ac, and H3K27ac, 
respectively, together with H2A, H2B, H4, and P601 DNA (Figure 30). These acetyl-
nucleosomes (0.66 μM) were then reacted with 0.33 μM Sirt6 for 3 h before they were 
analyzed in a native PAGE gel for EtBr staining and then transferred to a membrane for 
probing with a pan anti-Kac antibody (Figure 33B). In the EtBr stained gel, parallel 
samples that were incubated with and without Sirt6 showed similar intensities, indicating 
that Sirt6 did not dissolve any acetyl-nucleosome substrate. In the western blot analysis, 
the pan anti-Kac antibody showed very different detect detection abilities toward three 
acetylation sites. Although all three original acetyl-nucleosomes were detected by the 
pan anti-Kac antibody, signals for H3K9ac- and H3K27ac-nucleosomes were much 
stronger than that for H3K18ac-nucleosome. Notwithstanding different detection 
abilities of the pan anti-Kac antibody toward three acetylation sites, all three acetyl-
nucleosome samples that reacted with Sirt6 displayed much decreased acetylation levels 
in comparison to their original counterparts. For H3K9ac- and H3K18ac-nucleosomes, 
no signal was detected, indicating total removal of acetylation; For H3K27ac-
nucleosome, there was residual acetylation after its reaction with Sirt6 but much weaker 
than acetylation of the original nucleosome. To demonstrate that Sirt6 targets H3K9, 
H3K18 and H3K27 for their deacetylation in cells, a Sirt6-coding pEGFP vector was 
constructed and transiently transfected into 293T cells for overexpressing Sirt6. Cell 
lysates from Sirt6-transfected and control cells were then separated and probed by 
specific antibodies raised for H3K9ac, H3K18ac, and H3K27ac. As shown in Figure 
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33C, Sirt6-transfected cells have much weaker acetylation at H3K9, H3K18, and H3K27 
than control cells. This result confirms that all three sites are indeed targeted by Sirt6 for 
deacetylation in cells. 
Figure 33 Sirt6 catalyzes deacetylation at H3 K9, H3 K18, and H 3K27. (A) The 
incorporation of AcK into a nucleosome. (B) Sirt6 activities on H3K9ac-, H3K18ac-, 
and H3K27ac-nucleosomes. Acetyl-nucleosomes (0.66 μM) were incubated with or 
without 0.33 μM Sirt6 for 3 h before they was analyzed by a native agarose gel. The top 
panel shows the EtBr stained agarose gel and the bottom panel shows the pan anti-Kac 
antibody detected acetylation levels at different samples. (C) Acetylation levels at H3 
K9, H3 K18, and H3 K27 in Sirt6-transfected and control cells.276   
 
Discussion. As a chromatin associated protein and a NAD+-dependent sirtuin 
enzyme, Sirt6 has long been recognized as a histone deacetylase but with puzzlingly low 
activities toward peptide substrates. We show in this report that Sirt6 has close to 
undetectable deacetylation activities toward all 9 tested monomeric acetyl-H3 substrates. 
Although Sirt6 has been recently discovered to have enhanced activities toward a 
peptide lysine with long chain fatty acylation, our efforts to make oc-H3 proteins and 
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fold them to corresponding oc-H3-H4 tetramers did not yield active substrates for Sirt6 
either. However, deacylation activities of Sirt6 toward several H3 lysine sites were 
immensely improved when corresponding acetyl- or oc-H3 proteins were assembled into 
their nucleosomal forms. Although the focus of our current study is to identify Sirt6-
targeted H3 lysine sites for deacetylation, our result raise an interesting question as to 
what are the real substrates of Sirt6 in cells? Are they free histones or their nucleosomal 
forms? In fact, in promoter and active transcribed gene body regions where Sirt6 are 
found primarily positioned220, chromatin is in a dynamic process of assembly and 
disassembly221. Sirt6 has the chance to interact with both free histones and nucleosomes. 
Our results imply that nucleosomes are real substrates of Sirt6 but do not rule out that 
Sirt6, as part of a large protein complex, catalyzes efficient deacetylation of free 
histones. As a matter of fact, a lot of histone epigenetic modifiers are found in large 
multi-subunit complexes that contain various histone or DNA recognition domains222-224, 
although there has been none of these types of reports about Sirt6. Another interesting 
question raised by the current study is how the nucleosome structure activates Sirt6. 
Sirt6 has a highly positively charged C-terminus. Chua et al. showed that the cleavage of 
this C-terminus from Sirt6 does not deactivate the enzyme but abolishes its binding to 
chromatin225. One explanation of this observation is that the C-terminus is involved in 
nonspecific electronic interactions with negatively charged DNA for recruiting Sirt6 to 
chromatin or nucleosome. However, DNA may also neutralize the positively charged C-
terminus and therefore allows Sirt6 to interact with positively charged histone tails for 
deacetylation. This aspect needs to be explored further. Another important feature of 
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Sirt6 the current study reveals is the preferential sequence contexts around its targeted 
lysine sites. Unlike Sirt1, Sirt2, and Sirt3197, 226, Sirt6 prefers to deacetylate lysine that is 
preceded with a positively charged arginine residue. This may be attributed to the 
negatively charged residue E189 at a loop region of Sirt6 that directly interacts with 
protein or peptide substrates. All other sirtuins have a glycine residue at this site that 
may define their nonspecific recognition of lysine for deacetylation. Among all four 
histones, lysine residues that undergo acetylation and also have a preceding arginine 
residue include H2A K36 and H4 K20. We predict they are also Sirt6 targeted 
deacetylation sites. Other lysine sites that can be potentially targeted by Sirt6 for 
deacetylation are H2B K12 and H2B K16. These two lysine sites naturally undergo 
acetylation and are preceded with a positively charged lysine residue that potentially 
interacts with E189 of Sirt6 for strong binding.  
Besides revealing important biochemical features of Sirt6, the current study also 
has strong biological implications. Reports have indicated that Sirt6 is frequently 
recruited to relevant gene promoters and represses gene transcription via removing 
acetylation at H3 K9227, 228 and H3 K56229, 230. Our results show that H3 K18 and H3 
K27 are targeted by Sirt6 as well for deacetylation. H3K18ac and H3K27ac are 
associated with active gene expression231. Targeting these two sites for deacetylation is 
expected to reinforce the transcriptional repression role of Sirt6. Functional redundancy 
of histone acetylation on chromatin regulation has been observed. For example, a single 
mutation of an N-terminal H3 lysine to glycine has little repression effect on gene 
expression in yeast. However, simultaneous mutations of all N-terminal lysines to 
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glycine significantly reduces yeast gene expression232. Thus, it is reasonable for Sirt6 to 
remove acetylation from multiple lysines to fulfill a strong gene transcription 
suppression role. By removing acetylation from H3 K9, H3 K18, and H3 K27, Sirt6 may 
also regulate functions of proteins that recognize acetylation at these three lysine sites. 
One bromodomain YEATS recognizes acetylation at H3 K9, H3 K18, and H3 K27 with 
similar binding affinities233. It is highly possible that Sirt6 regulates functions of 
YEATS-containing proteins such as AF9 and ENL by modulating acetylation at H3 K9, 
H3 K18, and H3 K27. Di- and trimethylation at H3 K27 (H3K27me2/3) has long been 
known for shutting down transcription234. H3K27me3 is an important mark for 
inactivated X chromosome. H3K27ac is associated with active transcription235 and is 
apparently antagonistic to the repression of gene transcription by H3K27me2/3. Sirt6 
may serve as an important mediator to switch H3K27 between these two antagonistic 
states.  
In cancer biology, H3K18ac is an important prognostic mark. Downregulation of 
H3K18ac has been found correlated with poor prognosis of pancreatic 
adenocarcinoma236 and low grade prostate cancer214. Patients with high H3K18ac show 
low resurgence of prostate cancer after treatment237. Incidentally overexpression of Sirt6 
is observed in prostate cancer cell line PC-3 and inhibition of Sirt6 leads to apoptosis of 
PC-3214. Our study provides the missing link between downregulation of H3K18ac and 
high expression of Sirt6 in PC-3. It is highly possible that Sirt6 changes prostate cancer 
development through its deacetylation of H3 K18 and Sirt6 itself can be a potential anti-
cancer drug target.  
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Previous studies showed that Sirt6 catalyzes deacetylation at H3 K56 on purified H3 and 
Sirt6 knockout mouse tissue had enhanced H3K56ac. Our results detected sluggish 
removal of acetylation and long chain fatty acylation from H3 K56 by Sirt6. According 
to current published nucleosomal structures238, H3 K56 directly interacts with the 
wrapping DNA. In this nucleosomal format we have also adopted in our study, H3 K56 
is blocked from access by Sirt6. However, in cells Sirt6 may involve additional cellular 
factors for direct deacetylation of H3 K56 on free H3 or positioning of DNA wrapping239 
could be different and expose H3 K56 for deacetylation. It is also possible that H3K56-
targeting histone acetyltransferases/deacetylases are regulated by Sirt6 in cells. 
Conclusion 
As a member of a highly conserved family of NAD+-dependent histone 
deacetylases, Sirt6 is a key regulator of mammalian genome stability, metabolism, and 
life span. Previous studies indicated that Sirt6 is hardwired to remove histone acetylation 
at H3K9 and H3K56. However, how Sirt6 recognizes its nucleosome substrates has been 
elusive due to the difficulty of accessing homogenous acetyl-nucleosomes and the low 
activity of Sirt6 toward peptide substrates. Based on the fact that Sirt6 has an enhanced 
activity to remove long chain fatty acylation from lysine, we developed an approach to 
recombinantly synthesize histone H3 with a fatty acylated lysine, Nε-(7-octenoyl)-lysine 
(OcK), installed at a number of lysine sites and used these acyl-H3 proteins to assemble 
acyl-nucleosomes as active Sirt6 substrates. A chemical biology approach that visualizes 
OcK in nucleosomes and therefore allows direct sensing of Sirt6 activities on its acyl-
nucleosome substrates was also formulated. By combining these two approaches, we 
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show that Sirt6 actively removes acylation from H3 K9, H3 K18, and H3 K27, has 
relatively low activities toward H3 K4 and H3 K23, and sluggishly removes acylation at 
H3 K14, H3 K36, H3 K56, and H3 K79. Unlike Sirt1 and Sirt2 that show no sequence 
preferentiality for their targeted lysine sites, Sirt6-targeted lysine sites display obvious 
sequence similarities with H3 K9, H3 K18, and H3 K27 preceded with an arginine 
residue and H3 K4 and H3 K23 preceded with a serine residue. Overexpressing Sirt6 in 
293T cells led to downregulated acetylation at H3 K18 and H3 K27, confirming these 
two novel Sirt6-targeted nucleosome lysine sites in cells. The discrepancy between the 
sluggish in vitro activity of Sirt6 on H3 K56 and the high downregulation of H3 K56 
acetylation in Sirt6-overexpressed cells may be due to additional cellular factors 
involved in direct deacetylation of H3 K56 by Sirt6 or regulation of H3 K56-targeting 
histone acetyltransferases/deacetylases by Sirt6 in cells. Given that downregulation of 
H3 K18 acetylation is correlated with poor prognosis of several cancer types and H3 
K27 acetylation antagonizes repressive gene regulation by di- and trimethylation at H3 
K27, our current study implies that Sirt6 may serve as a target for cancer intervention 




CHAPTER III  
IDENTIFICATION OF SIRT7 DEACYLATION TARGETS USING ACYL-
NUCLEOSOMES 
Introduction 
There exist seven sirtuins in humans, namely SIRT1-7.240, 241 Four of these, 
SIRT1, 2, 6, and 7, can translocate to the nucleus, and therefore potentially remove 
acylation from chromatin for regulating chromatin epigenetic marks.202, 242-244 Among 
these four sirtuins, SIRT7 is perhaps the least studied. Accumulating work suggests that 
SIRT7 has complex effects on cellular homeostasis, oncogenic potential, and cellular 
aging pathways.245 Multiple studies have observed high SIRT7 levels in cancers, 
including head and neck squamous cell carcinoma, colorectal cancer, early state and 
metastatic breast cancer, thyroid carcinoma, ovarian cancer, and gastric cancer, 
consistent with oncogenic functions of SIRT7.246-255 Moreover, SIRT7 represses 
transcription of several tumor suppressive genes through deacetylation of histone H3 
lysine 18 (H3 K18ac), and depletion of SIRT7 is sufficient to reduce malignant 
properties of cancer cells and inhibit tumor growth in mice.251, 256 SIRT7 is enriched in 
nucleoli, and associates with both euchromatic and heterochromatic ribosomal RNA 
genes (rDNA).244, 257, 258. At euchromatic rDNA genes, SIRT7 deacetylates the RNA 
polymerase I (Pol I) subunit PAF53, which leads to enhanced interactions with rDNA for 
active transcription.244, 259 This SIRT7-dependent rRNA synthesis may help support the 
high ribosome biogenesis, proliferative capacity, and metabolic demands of cancer 
cells.260 However, SIRT7 also has tumor suppressive functions, and SIRT7-deficient 
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mouse embryonic fibroblast cells show increased cell viability and cell-cycle entry into 
S and G2/M.261-264  Moreover, SIRT7 is recruited to DNA double-strand breaks (DSBs) 
and protects against DNA damage by promoting recruitment of 53BP1 for initiating 
Non-homologous End Joining.265, 266 Recently, SIRT7 was also shown to guard against 
genomic instability due to rDNA rearrangements in nucleoli, by maintaining rDNA 
heterochromatin silencing.258 This function of SIRT7 is important for preventing 
senescence of human cells, which can contribute to tissue dysfunction in many aging-
related pathologies and favor tumor growth in cancers. Thus, SIRT7 has pleiotropic 
effects on genomic stability and cellular homeostasis pathways that can impact on cancer 
and aging biology.  
Although much evidence has established SIRT7 as a bona fide histone 
deacetylase, molecular details of SIRT7 interactions with chromatin for deacetylation 
have not been directly investigated. Two recent studies showed that both DNA and RNA 
can activate SIRT7.267, 268 However, the mechanism of this activation process is yet to be 
illustrated. In the current study, we re-constituted in vitro acyl-nucleosomes that have 
acyl-lysines installed site-specifically at a number of native histone H3 lysine sites and 
used these recombinant acyl-nucleosomes as substrates to systematically investigate 
SIRT7 recognition of histone lysines for deacylation in the physiologic context of 
chromatin. In addition to confirming the SIRT7 deacylation activity on H3 K18, we have 
uncovered a novel histone substrate of SIRT7, H3 K36. We show that SIRT7 is a highly 
active, physiologic H3 K36 deacylase, and this activity is nucleosome or chromatin 
dependent and can be significantly enhanced when free DNA is appended to the acyl-
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nucleosome substrate. This novel activity of SIRT7 may serve a pivotal role in guarding 
against genomic instability and human cellular senescence in cancer and aging-related 
pathology. 
Experimental section 
Synthesis of NƐ-(7-azidoheptanoyl)-L-lysine hydrochloride (AzHeK) 
 
Figure 34 Synthetic route of AzHeK 
 
Synthesis of compound 3: 9.51 g of Boc-Lys(Cbz)-OH (2) (25 mmol, Sigma-
Aldrich) was dissolved in dry DMF, followed by the addition of K2CO3 (7.26 g, 52.5 
mmol). 3.44 mL of MeI (55 mmol) was gradually added and was let to stir overnight at 80 
oC. Then the reaction mixture was quenched by the addition of 50 mL H2O and extracted 
by EtOAc 30 mL for 3 times. The EtOAc layers were combined, washed with brine, and 
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dried by anhydrous Na2SO4. The crude product was then purified by the silica gel flash 
column chromatography (eluted at 10% EtOAc/hexane) to give an oil product (3) (9.6 g, 
97%).  
7-azidoheptanoic acid: To 9.14 g of bromoheptanoic acid (44.0 mmol) was added 
150 mL anhydrous DMF.  To the stirring solution was added 9.14 g NaN3 (140 mmol, 3.2 
eq.) at room temperature. The clear solution was warmed to 60 °C for a period of 6 h. The 
solution was then cooled to room temperature and diluted with 250 mL DCM.  The organic 
layer was washed with cold 1N HCl (7 x 100mL) and brine (2 x 250mL), then dried over 
anhydrous Na2SO4.  Filtration and removal of solvent afforded 7.09 g crude 7-
azidoheptanoic acid in 94% yield which was of suitable purity for continuing to next step.   
7-azidoheptanoic acid-OSu (5): 7-azidoheptanonic acid (5.0 g, 29.1 mmol) was 
added to a solution of N-hydroxysuccinimide (3.69 g, 32.1 mmol) in dichloromehane (100 
mL). The DCC (6.62 g 32.1 mmol) in dichloromethane was then added and the mixture 
was left stirred overnight at room temperature. Dicyclohexylurea was removed by 
filtration and the filtrate was concentrated under reduced pressure to yield 7-
azidoheptanoic acid-OSu white crystals.  This compound was directly used without further 
purification.  
Synthesis of compound 6: The solution of Boc-Lys(Cbz)-OMe (3) (3.9 g, 10 mmol) 
in methanol (100 mL) was added palladium on activated carbon (Pd 10%, 0.6 g, 0.6 
mmol). The mixture was stirred at room temperature with hydrogen bubbled through, 
where the reaction progress was monitored by TLC analysis. The reaction was terminated 
as the starting protected amino acid on TLC disappeared. Then the reaction mixture was 
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filtered through a celite cake packed on a Buchner funnel and the flowed-through solution 
was concentrated under reduced pressure to afford colorless oil that was characterized as 
the desired product (4). The product was directly used in the next step without further 
purification. 
To a solution of the above amine (~9.15 mmol) in anhydrous dichloromethane (90 
mL) cooled in an ice bath was added N, N-diisopropylethylamine (2.80 mL, 16.07 mmol) 
dropwise, which was followed by adding a solution of 7-azidoheptanoic acid-OSu (5) 
(2.69 g, 11.07 mmol) in dichloromethane (10 mL) dropwise over 20 min. The mixture was 
then stirred at room temperature for 12 h, and it was washed with sodium hydroxide 
solution (0.5 N, 20 mL) and brine (20 mL x 2), dried (Na2SO4), evaporated, and flash-
chromatographed (EtOAc/hexanes, 1:3) to give 6 (3.2 g, 79% for two steps). 
Synthesis of compound 1: The solution of 6 (3.0 g, 7.2 mmol) in a 1:1 mixture of 
methanol and THF (24 mL) was added into LiOH aqueous solution (1.0 M, 14 mL) and 
stirred at room temperature. The reaction progress was monitored by TLC analysis. After 
5 h, the spot representing the starting ester on TLC plate disappeared. The reaction mixture 
was then diluted with EtOAc/H2O. After partition, the organic layer was discarded and the 
aqueous layer was acidified by the addition of 3M HCl until pH was adjusted to 3-4. The 
mixture was than extracted with EtOAc twice. The organic layers were combined, washed 
with brine, dried over anhydrous Na2SO4, and concentrated to afford clear sticky oil as the 




The afforded acid from the previous step (2.7 g, 7.26 mmol) in dioxane (20 mL) 
was added into the HCl solution (4 M in dioxane, 3.6 mL). The mixture was stirred at 
room temperature. The reaction progress was monitored by TLC. After reaction for 3 h, 
the HCl solution was removed under reduced pressure. The afforded white solid was 
confirmed as compound 1 (1.5 g, 60% for two steps). 1H NMR (D2O, 300 MHz).4.10-3.98  
(m, 1H), 3.31-3.21 (m, 4H), 2.25-2.28 (m, 2H), 2.12-1.82(m, 2H), 1.67-1.45 (m, 























Figure 35 (continued) NMR spectra of NƐ-(7-azidoheptanoyl)-L-lysine hydrochloride 




Figure 35 (continued) NMR spectra of NƐ-(7-azidoheptanoyl)-L-lysine hydrochloride 





Expression and purification of Ub-K48Az. Ubiquitin gene fragment with a C-
terminal 6xHis tag was cloned into pETDuet-1 vector. An amber stop codon was 
introduced at K48 through site-directed mutagenesis. The resulting pETDuet-1-UbK48am 
was used to co-transform a CobB- E. coli BL21 (DE3) strain together with pEVOL-
OcKRS. A single colony was picked and inoculated into 2YT medium supplemented with 
100 g/mL ampicillin and 34 g/mL chloramphenicol. When OD600 reached to 0.6, 0.5 
mM IPTG, 0.2% (w/v) L-arabinose and 1 mM AzHeK were added into the culture to 
induce protein expression. Cells were further incubated for 5 hours at 37 ℃ before cell 
collection and the following protein purification. Ubiquitin with AzHeK incorporated at 
K48 was purified in the same procedure as chapter II with a yield of 18 mg/L.1 
Expression and Purification of histone H3 mutants incorporated with AzHeK. A 
pETDuet-1 vector with a human H3 gene with amber stop codon introduced at a specific 
lysine coding position was used to co-transform a CobB- E. coli BL21 (DE3) strain 
together with pEVOL-OcKRS. A Single colony was picked and inoculated into 2YT 
medium supplemented with 100 g/mL ampicillin and 34 g/mL chloramphenicol. When 
OD600 reached to 0.6, H3 expression was induced at 37 ℃ by adding 0.5 mM IPTG, 0.2% 
(w/v) L-arabinose and 1 mM AzHeK into the cell culture. Cells were harvested 6 h after 
induction, and histone H3 was purified according to procedures as chapter II. Yield of 
Histone H3 with AzHeK incorporated at different sites ranged from 12 mg/L-26 mg/L.  
The In Vitro Assembly of Az-nucleosomes for SIRT7 deacylation assays. Recombinant 
Histone His-TEV-H2A, His-TEV-H2B and His-SUMO-TEV-H4 were expressed and 
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purified according to procedures reported in a previous publication.1 All histone pellets 
were dissolved in 6 M GuHCl buffer (6 M guanidinium hydrochloride, 20 mM Tris, 500 
mM NaCl, pH 7.5), and concentration was measured by UV absorption at 280 nm in a 
BioTek synergy H1 plate reader. To prepare H2A/H2B dimer, His-TEV-H2A and His-
TEV-H2B were mixed in the molar ratio of 1:1, and 6 M GuHCl buffer was added to 
adjust total protein concentration to 4 mg/mL. The denatured His-TEV-H2A/His-TEV-
H2B solution was dialyzed sequentially at 4 ℃ against 2 M TE buffer (2 M NaCl, 20 
mM Tris, 1 mM EDTA, pH 7.8), 1 M TE buffer (1 M NaCl, 20 mM Tris, 1 mM EDTA, 
pH 7.8), and 0.5 M TE buffer (0.5 M NaCl, 20 mM Tris, 1 mM EDTA, pH 7.8). The 
resulting dimer solution was centrifuged at 14000 RPM for 5 min at 4 ℃ to remove 
precipitates. And its concentration was determined by UV absorption at 280 nm using 
the BioTek synergy H1 plate reader. Steps of His-TEV-H3/His-SUMO-TEV-H4 
tetramer refolding were generally similar to the refolding of the His-TEV-H2A/His-
TEV-H2B dimer except that the total protein concentration was adjusted to 2 mg/mL and 
there was no stirring in the sequential dialysis. To generate a histone octomer, the 
refolded His-TEV-H2A/Hi-TEV-H2B dimer was mixed with the refolded His-TEV-
H3/His-SUMO-TEV-H4 tetramer in a molar ratio of 1:1, and NaCl solid was added to 
adjust NaCl concentration to 2 M. A 601 nucleosome positioning DNA (147 bp or a 
longer one with 5bp, 10bp, or 20bp extension at both 5’ and 3’ ends) was prepared by 
polymerase chain reaction and purified with PCR cleanup kit (#2360250 Epoch Life 
Science). Purified 601 DNA was redissolved in 2 M TE buffer and added to histone 
octamer solution in the molar ratio of 0.9:1. Lower molar ratio of DNA may be added if 
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free DNA is present in the final gel shift analysis. 2 M TE buffer was added to adjust the 
final DNA concentration to about 2-3 uM. The DNA histone mixture solution was then 
transferred to a dialysis bag and placed inside about 200 ml 2 M TE buffer. While it was 
stirred at room temperature, Tris buffer with no salt (20 mM Tris, pH 7.8) was slowly 
added into the 2M salt buffer through a liquid transfer pump (#23609-170 VWR®). 
When salt concentration was reduced to about 200 mM (measured by EX170 salinity 
meter), the dialysis bag would be transferred to nucleosome storage buffer (20 mM Tris, 
20 mM NaCl, 1 mM EDTA pH 7.8) for another 4 h, and precipitation was removed 
through centrifugation at 14000 RPM and room temperature for 10 min. TEV protease 
was then added to the nucleosome solution (TEV: nucleosome 1:30, w:w) for about 1 h 
at 37 ℃. to remove all the histone tags. (Figure 36) Since the A260 absorption of a 
histone octamer is much lower than DNA, nucleosome concentration was determined by 
directly measuring A260 absorption in the BioTek synergy H1 plate reader. 
 
Figure 36 N-terminal tag didn’t affect refolding of H2A/H2B dimer, H3/H4 tetramer 




SIRT7 deacylation of Az-nucleosomes. Recombinant His-SIRT7 was expressed 
and purified from E. coli as reported previously by Lin et al.2 An az-nucleosome solution 
was first dialyzed to a SIRT7 assay buffer (20 mM Tris, 150 mM NaCl, pH 7.8) and then 
supplemented with 1 mM NAD+ and 0.5 mM β-ME. The total nucleosome concentration 
was adjusted to 1 uM by adding the SIRT7 assay buffer (20 mM Tris, 150 mM NaCl, pH 
7.8), and 0.5 uM SIRT7 was added to initiate the reaction. After 2 h, 20 mM nicotinamide 
was added to quench the reaction and 0.1 mM DBCO-MB488 (#1190-5 Click Chemistry 
Tools) was added to label unreacted az-nucleosomes for 1 h at room temperature. 
Deacylation products were then displayed by 8% Native TBE-PAGE gel electrophoresis, 
and deacylation percentage was obtained by comparing the fluorescent signal strength of 
nucleosome bands between the sample incubated with SIRT7 and control sample with no 
SIRT7 treatment. Fluorescent signals were normalized with EtBr staining signal of 
nucleosome bands. Both DBCO-MB488 and EtBr fluorescence were imaged and 
quantified by Bio-Rad Chemidoc XRS+. For time-dependent assay, 20 mM nicotinamide 
was added at each time point to quench the reaction and then the reaction tube was put on 
ice until all reactions finished.  
SIRT7 deacylation of the H3K36Az-H4 tetramer. For the H3K36Az-H4 tetramer 
deacylation assay, the reaction solutions were prepared according to the following 
conditions: 1 uM His-SIRT7, 2 uM H3K36Az-H4 tetramer, 1 mM NAD+, 0.5 mM β-ME, 
20 mM Tris, 150 mM NaCl, pH 7.8 and 0.4 uM, 1 uM, 2 uM, or 4 uM free 147 bp 601 
DNA.  After incubating this reaction solution at 37 ℃ for 4 h, 20 mM nicotinamide was 
added to quench the deacylation, and 0.15 mM DBCO-MB488 dye was added to label 
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unreacted H3K36Az for 1 h at room temperature. 5 mM AzHeK was added to quench the 
unreacted DBCO dye and 2 U/unit DNase1 (ThermoFisher #M0303S) was added to digest 
free DNA. All reaction solutions were then flash-frozen by liquid nitrogen and 
lympholized to powders. The pellets were re-dissolved by 8 M Urea buffer (8 M Urea, 20 
mM tris, pH 7.8), and 4X SDS buffer was added to boil the samples to 95℃ for 10 min, 
which were then separated in 15% PAGE gel. DBCO-MB488 fluorescent signals of 
histone H3 band was imaged by Bio-Rad Chemidoc XRS+. Deacylation percentage was 
derived from the DBCO-MB488 signal differences between control sample that was not 
treated with SIRT7 and reaction samples that were treated with SIRT7 and also had 
different amounts of DNA in their reaction mixtures. Gels were counterstained by Brilliant 
Blue G250 and imaged by Bio-Rad Chemidoc XRS+.  
SIRT7 deacetylation of Ac-nucleosomes. H3 mutants with acetyl-lysine 
incorporated at various sites were expressed and purified from a CobB- E. coli BL21(DE3) 
strain according to procedures in our previous report.1 Through PCR, biotinylated primers 
were used to prepare biotinylated 601 nucleosome positioning DNA, which was used later 
to assemble biotinylated ac-nucleosomes. For SIRT7 assay with biotinyl-ac-nucleosomes, 
5 ul (total volume) of streptavidin resin (#L00353 GenScript) was added to a 20 ul 
reaction. At room temperature, the mixture was re-suspended 3 times once every 3 min, 
and centrifuged at 3000 RPM for 4 min. Supernatant was removed carefully by pipets, and 
50 ul SIRT7 assay buffer was added to wash streptavidin resin twice. Histone proteins 
were eluted from streptavidin resin by adding 8 M urea buffer (8 M urea, 20 mM tris, 500 
mM NaCl, pH 7.8) and 4X SDS loading buffer. After incubation at room temperature for 
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5 min, the mixture was centrifuged at 3000 RPM for 4 min and supernatant was boiled up 
and loaded onto 15% SDS-PAGE electrophoresis. Histone bands were transferred to 
nitrocellulose membrane by a standard semi-dry method using a Bio-Rad Trans-Blot 
Turbo transfer system. The membrane was coated with 5 % (w/v) fat-free milk (10 mL) 
for 1 h at room temperature and then treated with site-specific histone H3 acetylation 
antibody (#9927, #27683, Cell Signaling Technology) overnight at 4 ℃. The membrane 
was then washed with PBST buffer (10 ml PBS with 0.1% Tween-20) for 6 times with 2 
min intervals, and then the membrane was treated with secondary antibodies for 1 h at 
room temperature. (#111-035-144, Jackson ImmunoResearch). After being washed by 10 
ml PBST buffer for 6 times with 2 min interval, the membrane was treated with Pierce 
ECL Plus western substrates (#32132 ThermoFisher) and imaged by Bio-Rad Chemidoc 
XRS+.  
Validation of H3K18ac and H3K36ac as in vivo targets of SIRT7. A human SIRT7 
gene was cloned from a Pet28a-SIRT7 vector (provided by Dr. Hening Lin’s group) to the 
pEGFP vector (#6085-1 Addgene) to afford pEGFP-SIRT7 and site-directed mutagenesis 
was used to generate an inactive H187Y mutant form of pEGFP-SIRT7. Then empty 
pEGFP, pEGFP-SIRT7 and pEGFP-SIRT7-H187Y plasmids were prepared by QIAGEN 
plasmid midi kits (#12143 QIAGEN), and transfected separately into HEK293T Cell 
cultures using Lipofectamine 3000 transfection reagents (#L3000008, ThermoFisher). 48 
h later when above 80% HEK293T cells exhibited strong fluorescence, 5 uM TSA 
(#T5582, Sigma-Aldrich) was added to cell culture to induce overall increase of histone 
acetylation. After additional 4 h of incubation, cells from each group were collected, re-
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suspended in a lysis buffer (10 mM Tris, 1 mM EDTA, 10 mM KCl, 1% Triton X-100, 5 
uM TsA, 20 mM nicotinamide, protease inhibitor cocktail (#P8340, Sigma) pH 7.5) and 
vortexed several times while being incubated on ice for 30 min. The lysate was then 
centrifuged at 14000 RPM for 15 min and supernatant (cytoplasmic portion and nucleic 
proteins) was removed. Histone proteins were extracted from chromatin pellets by adding 
0.2 N HCl and incubating on ice for 20 min. The supernatant that contained acidified 
histones was retrieved after being centrifuged at 14000 RPM and 4 ℃ for 20 min and 
neutralized by adding 1 M Tris buffer (pH 8.0). Histone concentration was determined by 
BCA assay (#23225 ThermoFisher). About 5ug of extracted histone mix was 
electrophoresed by 15% SDS-PAGE and transferred to PVDF membrane (#162-0177 
Bio-Rad) according to the standard semi-dry protocol using the Bio-Rad Trans-Blot Turbo 
transfer system. The membrane was blotted by site-specific acetylation antibodies (#9927, 
#27683, #9674 Cell Signaling Technology) in the same manner as shown the previous 
paragraph.  
Locus-specific monitoring of H3K36ac change in vivo. For ChIP experiments, 
control rabbit IgG, anti-H3 (Abcam), anti-H3K36ac (Active Motif or Millipore) were used 
in combination with Protein A coated magnetic beads (Dynabeads, Invitrogen #10001D). 
For ChIP sequencing, anti-H3K36ac (Active Motif) and Spike-in anti-H2Av (Active 
Motif) were used. For immunoblotting, the following antibodies were used: anti-H3 
(Covance), anti-H3K36ac (Millipore or Diagenode), anti-FBL (Abcam), anti-UBF 
(SCBT), anti-p84 (GeneTex), anti-SIRT7 (Covance), anti--tubulin (Millipore) in 
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combination with secondary anti-rabbit or anti-mouse conjugated to HRP (Jackson 
ImmunoResearch). Nucleolar fractionation was performed as previously described.3  
For chromatin immunoprecipitation experiments, U2OS cells were crosslinked 
with 1% formaldehyde for 5 minutes at room temperature and the reaction was quenched 
by adding glycine to a final concentration of 1.25 M for 5 more min at room temperature. 
Cells were washed twice with ice-cold PBS and ressuspended and sonicated in ChIP lysis 
buffer to generate 200-300 bp fragments. Chromatin was diluted with low-SDS RIPA 
buffer and 25 ug chromatin was incubated overnight at 4 ºC with antibody coated protein 
A beads. Next day, after 3x washes with RIPA buffer, followed by 1x wash with TE buffer, 
immunoprecipitated chromatin was reverse crosslinked and DNA was purified with a PCR 
purification kit. For ChIP-PCR, ChIP DNA was analyzed using SYBR Green Master Mix 
in a Lightcycler480 II (Roche). The following primers were used: RPS20,4 COPS2,4 
MRPS18b Forward ctcacccaggattggtagaaa - Reverse acgactcttagatcgcattgtt, 18S 
Forward aattgacggaagggcaccac – Reverse tcaatcctgtccgtgtccg. ChIP-seq library was 
constructed using the Truseq ChIP kit from Illumina following the manufacturer 
instructions. Sequencing was performed in a HiSeq Illumina4000 platform with 2x150 
reads. 0.05% Drosophila spike-in chromatin (Active Motif) was included for 
normalization.  
For the repetitive sequence analysis, PCT and CT consensus or chromosome-
specific sequences, and control sequences were obtained from Eymery et al.5 along with 
the 18S and 28S rDNA, and telomeric (TTAGGG)8 sequence. Because these sequences 
were shorter than the sequencing read length (150 bp), the number of reads containing the 
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analyzed sequences were counted, and up to two mismatches were allowed. The read 
counts for each sample were normalized to total read count.  
Nucleosome accessibility assay with restriction endonuclease Pst1. Modified 601 
nucleosome positioning DNA that contained a Pst1 site at the entry/exit nucleosome 
region was prepared as what was previously designed.6 Primers encompassing the mutated 
Pst1 restriction site were used to prepare modified 601 DNA through polymerase chain 
reaction and purified by a PCR cleanup kit (#2360250 Epoch Life Science). 
Mononucleosomes containing w.t. H3, H3K18ac and H3K36ac were assembled similar to 
az-nucleosomes, except an additional thermal repositioning step at 60 ℃ for 20 min to 
generate nucleosome samples with homogenous DNA positioning. The final nucleosome 
solutions were dialyzed to 20 mM Tris buffer (pH 7.9). For Pst1 digestion assay, 10X 
NEB3.1 buffer (#B7203S, NEB) was added to provide all buffer ingredients and 0.49 uM 
w.t., H3K18ac and H3K36ac nucleosomes were incubated with 2 U/ul Pst1 (#R0140S 
NEB) at 37 ℃. At each time point, 14 ul of reaction solution was taken out and added 2.5 
ul 100 mM EDTA solution to quench the reaction. Reaction products of each time points 
were electrophoresed by 5% Native 1X TBE-PAGE gel, and digestion efficiency was 
estimated by comparing the EtBr staining signal strength between original nucleosome 
band and the lower digested nucleosome band. 
Mass determination of Histone H3 protein using HPLC-MS. Histone pellets were 
dissolved in 0.1% (w/v) formic acid solution to final concentration of 1 mg/ml. 2 ul of 
Histone H3 solution was injected into Thermo Scientific Q Exactive Focus Orbitrap LC-
MS/MS System equipped with a Sigma BIOshell A400 Protein C4, 3.4 um HPLC 
 
105 
column (10 cm x 2.1 mm). Histone H3 was separated with a water/acetonitrile gradient 
with flow phase A as water with 0.1% (w/v) formic acid and flow phase B as acetonitrile 
with 0.1% (w/v) formic acid.  From 0 to 10 min, ran HPLC at 0.2 ml/min with linear 
gradient from 20% B to 60% B. From 10 to 15 min, ran at 0.2 ml/min with linear 
gradient from 60% B to 100% B. Then ran with 100% B at 0.2ml/min to clean up the 
column from 15 min to 20 min. ESI-MS data was acquired in the positive ion mode with 
the following parameters: Resolution: 70000, Range: 600-1400 m/z, AGC:3e6, Max 
inject time: 150ms, Sheath gas flow rate: 45, Aux gas flow rate: 30, Spray voltage 





































































Figure 37 (continued) ESI-MS spectra of recombinant histone Az-H3 and Ac-H3 
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Primers and gene sequences 
pEGFP-SIRT7 → pEGFP-SIRT7-H187Y: 
F-primer: TATGGGAACATGTACATTGAAGTCTGTACCTC  
R-primer: GAGCTCGGAGATGGCCGTG  
601 DNA with no linker DNA attached:  
F-primer: CTGGAGAATCCCGGTGCCG  
R-primer: ACAGGATGTATATATCTGACACGTGC  
601 DNA with 5bp linker DNA: 
F-primer: GTAATCTGGAGAATCCCGGTGCCG  
R-primer: TAAGGACAGGATGTATATATCTGACACGTGC  
601 DNA with 10bp linker DNA: 
F-primer: GTAATGTAATCTGGAGAATCCCGGTGCCG  
R-primer: TAAGGTAAGGACAGGATGTATATATCTGACACGTGC  
601 DNA with 20bp linker DNA: 
F-primer: GTAATGTAATGTAATGTAATCTGGAGAATCCCGGTGCCG  
R-primer: 
TAAGGTAAGGTAAGGTAAGGACAGGATGTATATATCTGACACGTGC  































Results and discussion 
A modified click chemistry-based assay for quick profiling of SIRT7-targeted 
chromatin lysine deacylation sites. Although originally defined as histone deacetylases, 
accumulated evidence has established that sirtuins catalyze the removal of a spectrum of 
acylation types from protein lysines.199, 267, 269-275 Therefore, they are more generally 
categorized as protein lysine deacylases. Specifically for SIRT7, studies have 
demonstrated that it catalytically removes fatty acyl and succinyl groups from histone 
lysines.267, 275 Through genetic incorporation of NƐ-(7-octenoyl)-lysine (OcK) into 
histones in conjunction with the alkene-tetrazine cycloaddition reaction to analyze fatty 
acylation levels in acyl-nucleosome substrates that we assembled in vitro from OcK-
incorporated histones, we previously revealed that SIRT6 is catalytically active to 
remove acylation from multiple H3 lysine sites.276 Given the structural similarity 
between SIRT6 and SIRT7 and the demonstrated activity of SIRT7 to remove fatty-
acylation from protein lysines, a similar approach might be applied to profile SIRT7-
targetted H3 lysine deacylation sites. However, the previously described alkene-tetrazine 
cycloaddition-based method has a significant drawback. The slow reaction (the second 
order rate constant: ~0.01 M-1s-1) between a terminal alkene and a tetrazine requires a 
long reaction time.218 Given the delicate nature of acyl-nucleosome substrates, this long 
reaction time is particularly undesirable. To accelerate the labeling reaction, we 
envisioned that N-(7-azidoheptanoyl)-L-lysine (AzHeK) could be installed in acyl-
nucleosome substrates and expected that AzHeK’s close mimic of N-decanoyl-L-lysine 
(DeK) would allow efficient recognition by SIRT7 for defatty-actylation. AzHeK has an 
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azide functionality that reacts favorably with a dibenzocyclooctyne (DBCO) dye (the 
second order rate constant: ~1 M-1s-1)277-279 for quick labeling of acyl-nucleosome 
substrates. Therefore, we can potentially use acyl-nucleosomes with AzHeK installed at  
different H3 lysine sites as SIRT7 substrates for defatty-acylation and then analyze 
 
Figure 38 A click chemistry-based approach to profile SIRT7-targeted chromatin lysine 
deacylation sites. AzHeK that structurally resembles DeK is site-specifically 
incorporated into a histone that is further assembled in vitro with other histones and 601 
DNA into an acyl-nucleosome. This acyl-nucleosome can be fluorescently labeled with a 
strained alkyne dye and subsequently visualized in a 1 TBE native-PAGE gel. When 
SIRT7 is catalytically active to remove fatty acylation from the incorporated AzHeK to 
recover lysine, incubating the assembled acyl-nucleosome with SIRT7 will remove the 
fatty acylation and therefore afford a deacylated nucleosome that cannot be fluorescently 
labeled and then visualized in a gel. 
 
relative activities of SIRT7 toward different acyl-nucleosomes by probing residual fatty-
acylation on these substrates using a DBCO dye when their reactions with SIRT7 finish 
(Figure 38). Accordingly, an effective assay for profiling SIRT7 targeted H3 lysine 
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deacylation sites can be potentially developed. This novel assay will allow not only 
straightforward determination of SIRT7 deacylation activities at different nucleosome 
lysine sites but also their kinetic characterization. In comparison to antibody-based 
detection, this designed assay is much simpler and more accurate. 
The genetic incorporation of AzHeK into a protein allows its click labeling with a 
strained alkyne dye. Following a synthetic route shown in Figure 34, we synthesized 
AzHeK in a large quantity. For its genetic incorporation, we employed our previously 
identified OcKRS.276 We have shown that this MmPylRS mutant actively charges 
tRNAPyl with OcK and DeK for their incorporation at amber codon during translation in 
E. coli (data not shown). When growing E. coli BL21(DE3) cells that harbored plasmids 
coding genes for OcKRS, 𝑡𝑅𝑁𝐴 , and ubiquitin-6His with an amber mutation at the 
K48 position in the presence of 1 mM AzHeK, we successfully induced the expression 
of full-length ubiquitin UbK48az (Figure 39b). The expression level was 18 mg/L, 
equivalent to the expression of Ub with OcK incorporated at K48. Wild type Ub has an 
expression level around 100 mg/L in the same conditions. On the contrary, we were not 
able to induce the expression of ubiquitin when AzHeK was absent. After incubating 
UbK48az with 100 M MB488-DBCO, a strained alkyne dye for 1 h, we observed a 
strongly labeled ubiquitin band when we analyzed the protein fluorescently in a SDS-
PAGE gel (Figure 39c). However, we were not able to label wild-type ubiquitin using 
the same condition. In comparison to the previous alkene-tetrazine cycloaddition-based 
labeling that requires a minimum of 8 h for close to 40% labeling of a OcK-containing 
protein in the presence of a 200 M tetrazine dye, this new labeling was much quicker 
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and led to close to quantitative labeling in about 30 min (Figure 40a). The azide group 
in UbK48az was stable at room temperature for about 1 h when 1 mM  -
mercaptoethanol (BME) was present (Figure 40b). We also characterized the purified 
UbK48az using MALDI-TOF mass spectrometry (Figure 40d). The MALDI-TOF-MS-
determined molecular weight (9540.9 Da) agreed well with the calculated one (9540.7 
Da). 
 
Figure 39 genetic incorporation of AzHeK into Ubiquitin at K48 position. (a) AzHeK 
incorporated at K48 position of ubiquitin could be site-specifically labelled by DBCO-
MB488 through copper-free click reaction (b) test of AzHeK incorporation efficiency 
with previously reported mmOcKRS/tRNAPyl pair in E. coli BL21(DE3) CobB- cell line 
in the following condition: 0.5 mM IPTG, 0.2% (w/v) L-arabinose, 1 mM AzHeK. (c) 
Labeling test of Ub-K48Az with DBCO-MB488 in the following condition: 5 uM 
ubiquitin, 0.1 mM DBCO-MB488, PBS buffer, pH 7.4. (d) MALDI-TOF mass of 
UbK48-AzHeK (measured: 9541.0, calculated: 9540.8) 
 
SIRT7 catalyzes removal of acylation from H3 K18 and H3 K36 in the context of 
nucleosomes. After confirming that OcKRS was efficient in mediating the genetic 




Figure 40 (a) Time-dependent labeling of Ub-K48Az by DBCO-MB488 in the 
following conditions: 5 uM UbK48Az, 0.1 mM DBCO-MB488, PBS buffer pH 7.4 at r.t. 
(b) AzHeK stability in the presence of β-ME (Upper lane: Commassie blue staining; 
Bottom lane: FITC signal detection). (c) Labeling of His-TEV-H3K36Az by DBCO-
MB488 caused band position shift on the 15% PAGE gel. 
 
proteins with AzHeK incorporated at K4, K9, K14, K18, K23, K27, K36, and K56, 
respectively. These AzHeK-containing H3 histones were named as H3K4az, H3K9az, 
and so on. To recombinantly produce a specific AzHeK-containing H3 protein, we 
transformed E. coli BL21(DE3) cells with pEVOL-OcKRS that contained genes coding 
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OcKRS and 𝑡𝑅𝑁𝐴  and a pETDuet-H3 vector that contained a N-terminally 6His-
fusing H3 gene with an amber mutation introduced at a designated lysine coding site and 
grew the transformed cells in 2YT media supplemented with 1 mM AzHeK. We 
successfully expressed all eight proteins and affinity-purified them using Ni-NTA resins 
(Figure 41a). Electrospray ionization mass spectrometry (ESI-MS) analysis of purified 
proteins confirmed the incorporation of AzHeK (Figures 37). Using these recombinantly 
produced acyl-H3 proteins together with H2A, H2B, H4, and 601 DNA,280 we succeeded 
in reconstituting corresponding acyl-nucleosomes, namely as nu-H3K4az, etc. that we 
visualized using ethidium bromide (EtBr) staining in a polyacrylamide gel (Figure 41b). 
We then subjected these in vitro assembled acyl-nucleosomes to deacylation by SIRT7. 
Acyl-nucleosomes treated with and without SIRT7 were then labeled with MB488-
DBCO and imaged in 5% 1X TBE Native-PAGE gels. As shown in Figure 41c, SIRT7 
removed acylation from H3 K18 and H3 K36 but was not active toward other lysine 
sites. The deacylation activity of SIRT7 on H3 K36 is clearly much higher than that on 
H3 K18. The fluorescent gel showed total removal of acylation at H3 K36 but residual 
acylation on H3 K18. H3 K18 was a previously demonstrated lysine deacylation site for 
SIRT7. However, SIRT7-catalyzed deacylation activity on H3 K36 came as a surprise. 
We went further to quantify deacylation activities of SIRT7 on all tested sites. In the 
given deacylation conditions in which a 1 uM acyl-nucleosome was incubated with 0.5 
uM SIRT7 and 1 mM NAD+ at 37 C for 2 h, the deacylation activity of SIRT7 on H3 






Figure 41 SIRT7 actively removes acylation from H3 K18 and H3 K36 in the 
nucleosome context. (a) SDS-PAGE analysis of eight purified AzHeK-containing H3 
proteins. (b) Acyl-nucleosomes that we assembled from eight acyl-H3 proteins, H2A, 
H2B, H4, and 601 DNA (147 bp). Nu-H3K4az denotes an acyl-nucleosome assembled 
from H3K4az. All other acyl-nucleosomes are named in the same way. 
Mononucleosomes are typically shown around the 500 bp DNA position in an EtBr-
stained 5% 1 TBE native-PAGE gel. (c) SIRT7 catalyzed deacylation activities on 
eight acyl-nucleosome substrates. Reaction conditions: we incubated 1 M acyl-
nucleosome with 0.5 M SIRT7, 0.5 mM BME and 1 mM NAD+ at 37 C for 2 h before 
we quenched the reaction by the addition of 20 mM nicotinamide. We then labeled the 
resulted acyl-nucleosome substrate with 100 M MB488-DBCO for 1 h and analyzed it 
fluorescently in an 8% 1 TBE native-PAGE gel. The top panel shows the MB488-
DBCO-based fluorescent imaging and the bottom panel shows the EtBr-stained DNA 
from the same gel. (d) Quantified deacylation levels at eight H3 lysine sites. We 
repeated experiments shown in C thrice and calculated the deacylation level at each site 
by subtracting average MB488-DBCO-based fluorescence intensity of SIRT7-treated 
samples from that of untreated controls.   
 
DNA and salt inhibit SIRT7-catalyzed nucleosome deacylation. Since a previous 
study reported that DNA activates SIRT7-catalyzed deacetylation on peptide 
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substrates,268 we investigated whether it has the same effect on SIRT7-catalyzed 
nucleosome deacylation. We used nu-H3K36az as a SIRT7 substrate and tested its 
deacylation by SIRT7 when we provided different concentrations of free 147 bp 601 
DNA in the reaction solution. As shown in Figure 42a, SIRT7 strongly removed 
acylation from nu-H3K36az but this activity decreased significantly when we provided 
free DNA to the reaction solution and was close to be abolished when 2 M free DNA 
was present. Thus, DNA apparently inhibits SIRT7-catalyzed nucleosome deacylation. 
Free DNA is negatively charged. It interacts electrostatically with both a positively 
charged histone-based peptide substrate and SIRT7 that has positively charged N- and C-
termini. Therefore, it potentially serves as a bridge to bring SIRT7 and a peptide 
substrate in close proximity for improved deacetylation. We suspected that the wrapping 
DNA in an acyl-nucleosome substrate might play a similar role to interact 
electrostatically with SIRT7 for improved deacylation. To test this prospect, we 
examined SIRT7-catalyzed deacylation of nu-H3K36az in different concentrations of the 
NaCl salt. If interactions between SIRT7 and nu-H3K36az are electrostatic in nature, 
increasing ionic strength of the reaction solution by providing NaCl will disrupt the 
binding of SIRT7 to nu-H3K36az and therefore leads to a lower deacylation activity. As 
expected, the SIRT7-catalyzed deacylation activity on the nu-H3K36az substrate 
diminished gradually when more salt was present in the reaction solution (Figure 42b). 
To confirm that free DNA does serve as a bridge to bring SIRT7 and a peptide or protein 
substrate into close proximity for improved deacylation activity, we tested the SIRT7-




Figure 42 Effects of DNA and salt on SIRT7-catalyzed deacylation. (a) Free DNA 
inhibits SIRT7-catalyzed nucleosome deacylation. Reaction conditions: we incubated 1 
M nu-H3K36az with 0.1 M SIRT7, a varied concentration of 147 bp DNA, 1 mM 
NAD+ and 0.5 mM BME at 37 C for 3 h before we labeled the solution with 100 M 
MB488-DBCO and analyzed the acyl-nucleosome substrate fluorescently in a 1 TBE 
native-PAGE gel. The top panel is MB488-DBCO-based imaging that indicates relative 
acylation levels and the bottom panel is EtBr-based imaging that confirms the 
nucleosome integrity. (b) Salt inhibits SIRT7-catalyzed nucleosome deacylation. 
Conditions were as same as in A except we replaced free DNA with NaCl. (c) Free DNA 
has a binary role on SIRT7-catalyzed deacylation of the H3K36az-H4 tetramer substrate. 
Reaction conditions: we incubated 2 M H3K36az-H4 tetramer with 1 M SIRT7, a 
varied concentration of 147 bp DNA, 0.5 mM BME, and 1 mM NAD+ 37 C for 2 h 
before we labeled the solution with 100 M MB488-DBCO and analyzed the tetramer 




presence of various concentrations of free DNA. The result is shown in Figure 42c. 
Similar to its low activity toward H3K36ac, SIRT7 displayed a marginal deacylation 
activity on the H3K36az-H4 tetramer when free DNA was absent. However, this activity 
was significantly enhanced when we added 0.4 M DNA into the reaction solution. 
When we added more DNA, this activity diminished gradually until it was almost totally 
abolished. This phenomenon is similar to what we observed with the nu-H3K36az 
substrate. 
SIRT7 is more active toward acyl-nucleosomes with linker DNAs. In chromatin, a 
bridging linker DNA that binds loosely to H1 and transcription factors connects two 
adjoining nucleosomes. To determine whether this linker DNA contributes to SIRT7 
binding to an acyl-nucleosome for active deacylation, we synthesized nu-H3K18az and 
nu-H3K36az nucleosomes with different lengths of linker DNAs and used them as 
substrates to test SIRT7-catalyzed deacylation (Figures 43a & b). Appending a linker 
DNA to nu-H3K36az significantly improved SIRT7-catalyzed deacylation (Figure 43c). 
A 5 bp linker DNA led to more than 3-fold deacylation activity increase (Figure 43e). 
Increasing the linker DNA length from 5 bp to 20 bp slightly enhanced SIRT7 
deacylation activity at H3 K36 but not to a significant level. Although appending the nu-
H3K18az substrate with a linker DNA also improved SIRT7-catalyzed deacylation at H3 
K18, this activity increase was much less significant than what we observed for the nu-
H3K36ac substrate (Figures 43d & f). On the contrary, appending a linker DNA to nu-
H3K4az, nu-H3K9az, nu-H3K14az, H3K23az, and H3K27az did not improve their 




Figure 43 A linker DNA on an acyl-nucleosome substrate improves SIRT7-catalyzed 
deacylation. (a) A diagram to illustrate how a linker DNA affiliates the binding of 
SIRT7 to an acyl-nucleosome substrate. (b) The in vitro assembly of nu-H3K18az and 
nu-H3K36az with different lengths of linker DNAs. The gel showed the EtBr-stained 
nucleosomes. (c) The catalytic removal of acylation from nu-H3K36az substrates that 
contained different lengths of linker DNAs. Reaction conditions: we incubated a 1 M 
H3K36az nucleosome with 0.1 M SIRT7, 1 mM NAD and 0.5 mM BME at 37 C for 
various times before we quenched the reaction by adding 20 mM nicotinamide, labeled 
the solution with 100 M MB488-DBCO for 1 h, and then analyzed the nucleosome 
substrate fluorescently by 8% 1 TBE native-PAGE gel. (d) The catalytic removal of 
acylation from nu-H3K18az substrates that contained different lengths of linker DNAs. 
Reaction conditions were as same as for nu-H3K36az substrates except higher amount of 
SIRT7 (0.3 M) was used. (e-f) Quantified deacylation percentage vs time for two acyl-
nucleosome substrates. Reactions shown in c and d were repeated thrice. Deacylation 
was calculated and averaged by subtracting MB488-DBCO-based fluorescence intensity 




Figure 44 SIRT7 site-specificity test on Az-nucleosomes with 20bp linker DNA. 
Reaction condition: 1 uM nucleosome, 0.2 uM SIRT7, 1 mM NAD+, 0.5 mM β-ME, 
37℃, 2h. 
 
SIRT7 catalyzes removal of nucleosomal H3 K36 acetylation in vitro and in cells. 
Our finding that H3 K36 is a preferential SIRT7-targeted lysine site for defatty-acylation 
led us to ask if SIRT7 is also catalytically active in removing acetylation at H3 K36 both 
in in vitro biochemical assays and in cells. We assembled two in vitro nu-H3K36ac 
nucleosomes using 147 bp 601 DNA with or without a 20 bp linker DNA (Figure 46). 
We then incubated these two nucleosomes with SIRT7 in deacetylation reactions and 
subsequently detected acetylation levels of the reaction products by Western blotting 
with an anti-H3K36ac antibody. The result revealed that SIRT7 deacetylated H3 K36 in 
the context of nucleosomes, and appending a linker DNA significantly improved this 
deacetylation activity (Figure 45a). To test SIRT7 activity on other nucleosomal H3 
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lysine, sites, we also reconstituted several other acetyl-nucleosomes including nu-
H3K9ac, nu-H3K14ac, nu-H3K18ac, nu-H3K27ac, and nu-H3K56ac (Figure 46) for use 
as substrates in SIRT7 deacetylation assays. All acetyl-nucleosomes contained a 20 bp 
linker DNA for improving SIRT7 activities. Our data confirmed that SIRT7 is 
catalytically active in deacetylation of H3 K18 but is inert toward all other lysine 
acetylation sites tested, and the deacetylation activity of SIRT7 on H3 K18 is much 
weaker than that on H3 K36. To examine the deacetylase activity of SIRT7 on H3 K18 
and H3 K36 in cells, we constructed two plasmids, one encoding a SIRT7-EGFP fusion 
gene and the other a SIRT7-EGFP fusion gene with a H187Y mutation to inactivate the 
SIRT7 activity, from a mammalian pEGFP vector. Together with the original pEGFP 
vector, we transiently transfected 293T cells separately with all three plasmids. We 
separated cell lysates from these three transiently transfected cells using SDS-PAGE and 
then analyzed different histone acetylation levels using antibodies that recognize 
acetylation at K9, K14, K23, K27, and K36 of H3, respectively. These assays revealed 
significantly decreased acetylation levels at H3 K18 and H3 K36 in cells with 
overexpressed SIRT7-EGFP but not in cells that transfected with the empty control 
vector or expressing the inactive SIRT7-H187Y-EGFP fusion protein. These data 
demonstrate that SIRT7 is catalytically active in deacetylating both H3 K18 and H3 K36 




Figure 45 Assembly of H3 ac-nucleosomes 
 
SIRT7 is essential for maintaining low H3K36ac levels at nucleolar rDNA 
sequences and select gene promoters. We next asked if H3K36Ac is a physiologic 
substrate of SIRT7, and if endogenous SIRT7 is important for setting baseline levels of 
H3 K36 acetylation. We generated SIRT7-deficient cells by shRNA-mediated 
knockdown strategies, and assayed levels of H3K36Ac in whole cell extracts by Western 
analysis (Figure 47a). We observed significantly increased H3K36 acetylation in the 
SIRT7-depleted cells. We also examined locus-specific H3K36ac levels at promoters of 
previously described genomic targets of SIRT7 by chromatin immunoprecipitation 
(ChIP).256 In SIRT7-depleted cells, levels of H3K36ac were significantly increased at 
two ribosomal protein gene targets of SIRT7, but not at another SIRT7 target, COPS2 
(Figure 47b). Importantly, we confirmed these findings using an independent H3K36ac 




Figure 46 Validation of H3K36ac as SIRT7 targets both in vivo and in vitro. (a) SIRT7 
deacetylation assay on acetyl-nucleosome in the following condition: 1 uM nucleosome, 
0.2 uM SIRT7, 1 mM NAD+, 0.5 mM β-me, 37 ℃, 2 hours. Western blot bands on the 
upper panel were blotted by site-specific acetyl-histone antibodies, bands on the bottom 
panel were blotted by wildtype H3 antibodies. (b) global histone H3 acetylation level 
change after SIRT7 overexpression. EGFP, SIRT7-EGFP and inactive SIRT7-H187Y-
EGFP mutant were transiently overexpressed in HEK293t cell, histones were extracted 
and acetylation levels were estimated by western blot.     
 
characterized (Figure 47b). SIRT7 is reported to be enriched in nucleoli based on 
immunofluorescence studies. To examine changes in H3 K36 acetylation specifically in 
nucleoli, we carried out biochemical fractionation of SIRT7-deficient and control cell 
extracts into nucleolar and nucleoplasmic (non-nucleolar) fractions. Immunoblot 
analysis revealed that both nucleolar and nucleoplasmic levels of H3K36ac are 
dramatically increased in SIRT7-depleted cells compared to control cells (Figure 47c). 
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To further validate these findings in cells completely lacking SIRT7, we used 
CRISPR/Cas9 targeting to generate two independent SIRT7-knockout cell lines and a 
non-targeted control-treated cell line. Nucleolar fractionation of the cells confirmed the 
dramatic increase in H3K36ac levels in both nucleoli and nucleoplasm of SIRT7- 
knockout cells (Figure 47d). Importantly, in the control cells, H3K36ac levels (relative 
to total H3) were much lower in nucleoli than nucleoplasm, and this inversely correlated 
with SIRT7 levels in those nuclear compartments. This further underscores the 
physiological relevance of SIRT7 deacetylase activity on H3K36ac levels in a non- 
perturbed system. The main DNA components of nucleoli are rDNA genes. To directly 
assess H3K36 acetylation changes at rDNA, we analyzed H3K36ac ChIPs from SIRT7-
deficient and control cells using real-time PCR or unbiased high-throughput sequencing 
The ChIP-PCR revealed significantly increased H3K36ac occupancy at rDNA sequences 
(Figure 47e). Notably, analysis of the high-throughput sequencing reads from the ChIPs 
confirmed these findings, and showed that the increase in H3K36ac is quite specific to 
rDNA compared to other repetitive regions of the genome, as no significant changes in 
acetylation were observed at repetitive sequence tracts present at over 20 different 
centromeric and pericentromeric regions, or when queried for eight different centromeric 
and pericentromeric consensus repeat sequences (Figure 47f).281 Finally, this analysis 
also revealed an intriguing and unexpected increase in H3K36ac occupancy at TTAGGG 
repeats, which are present at telomeres. Together, our studies demonstrate that SIRT7 is 
a novel physiologic H3K36 deacetylase, and is essential for maintaining low H3K36 
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acetylation levels at rDNA sequences in nucleoli, certain protein-coding genes, and 
possibly telomeric DNA. 
H3 K36 acylation leads to a loose nucleosome complex. H3 K36 is located at the 
entry and exit sites of DNA in the nucleosome dyad. Its positively charged side chain 
amine can interact directly with a negatively charged DNA backbone phosphate. This 
potential electrostatic interaction is expected to contribute to a tightly bound nucleosome 
complex that prevents the access of H3 K36 by enzymes and transcription factors 
including SIRT7. The disruption of this electrostatic interaction by H3 K36 acylation 
will weaken the binding of DNA to the nucleosome core, therefore leading to more 
frequent unwrapping of DNA from core histones and consequently more accessibility to 
enzymes and transcription factors. We think this potentially increased unwrapping of 
DNA from the nucleosome core assists SIRT7-catalyzed deacetylation at H3 K36. This 
improved unwrapping of DNA from the nucleosome core will also lead to more access 
of DNA by a nuclease (Figure 49a). To test whether H3 K36 acetylation improves DNA 
unwrapping, we introduced a Pst1 endonuclease restriction site at the entry/exit site of 
601 DNA that also contained a 20 bp linker DNA beyond the Pst1 restitution site and 
used this mutant 601 DNA to reconstitute three nucleosomes including wild type (nu’) 
with no histone modification, nu’-H3K18ac, and nu’-H3K36ac for analyzing effects of 
acetylation of H3 K18 and H3 K36 on Pst1-catalyzed restriction digestion of the 
wrapping DNA (Figure 48 and Figure 49b). We introduced the Pst1-cutting site at the 
entry/exit site in order to maintain the nucleosome integrity after Pst1- catalyzed 
restriction cleavage of the tail linker DNA fragment. Since the digested nucleosome has 
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Figure 47 SIRT7 is a physiologic nucleolar and nucleoplasmic H3K36 deacetylase. (a) 
Immunoblot showing increased H3K36ac levels in whole cell lysates from SIRT7 
knock-down (KD) U2OS cells compared to control cells. (b) ChIP-PCR showing 
increased H3K36ac levels at promoters of SIRT7 target genes RPS20 and MRPS18b, but 
not COPS2, in SIRT7 KD and control U2OS cells. Two independent H3K36ac 
antibodies (Ab 1 and 2) were used. Data show the average of three technical replicates 
+/- SEM, and are representative of 2-4 biological replicates. Statistical significance was 
calculated performing Student’s t-test. (c) Immunoblot of nucleolar fractionation 
showing increased levels of H3K36ac in SIRT7 KD cells versus control cells. -Tubulin, 
p84, and FBL or UBF are shown as marker controls for cytoplasmic, nucleoplasmic, and 
nucleolar fractions, respectively. (d) Immunoblot of nucleolar fractionation of SIRT7 
knockout versus control U2OS cells. (e) ChIP-PCR showing increased levels of 
H3K36ac at 18S rDNA sequences in SIRT7 KD cells. Data show the average of three 
biological replicates +/- SEM. Statistical significance was calculated performing 
Student’s t-test. (f) ChIP-seq enrichment analysis of H3K36ac at repetitive sequences in 
SIRT7 KD versus control U2OS cells. Bar plot of log10(p-value) shows statistically 
significant enrichment of H3K36ac in SIRT7-KD cells at rDNA (18S, 28S) and 
telomeric (TTAGGG) repeats, but not at repetitive sequences from 20 specific 
centromeres (CT), 6 specific pericentromeres (PCT), or 4 centromeric and 4 pericentric 






a shorter DNA, it will run faster than the original nucleosome and can be easily 
visualized in a 5% 1 TBE native-PAGE gel after EtBr staining. We included nu’-
H3K18ac in our analysis to see whether acetylation may generally increase DNA 
unwrapping from the nucleosome histone core. As shown in Figure 49c, Pst1 showed 
much higher activities to digest DNA in nu’-H3K18ac and nu’-H3K36ac than DNA in 
nu’ that had no histone lysine acetylation. The effect of H3 K36 acetylation is more 
significant than that of H3 K18 acetylation (Figure 49d). 
 
 
Figure 48 (a) Design of modified 601 DNA for the accessibility assay. (b) Thermal 








Figure 49 Lysine acetylation at H3 K36 improves DNA unwrapping from the 
nucleosome core. (a) A diagram to illustrate how H3K36ac increases DNA unwrapping 
from the nucleosome core and subsequent Pst1 access to an embedded Pst1 restriction 
site. (b) The in vitro assembly of three nucleosomes, nu’, nu’-H3K18ac, and nu’-
H3K36ac from corresponding histones and a mutant 601 DNA that had a Pst1 restriction 
site and a linker DNA. The gel shows EtBr-stained nucleosomes. (c) Pst1 digestion 
progress of three nucleosomes versus time. Reaction conditions: we incubated a 0.49 M 
nucleosome with 2 U/uL Pst1 at 37 C for various times before the reaction was stopped 
and the solution was analyzed by 5% 1 TBE native-PAGE. The gel was stained by 
EtBr. The top band in a lane shows the nucleosome with the linker DNA and the bottom 
band represents the one with the linker DNA removed. (d) The calculated ratio of 
digested nucleosome to undigested nucleosome versus time. We calculated and averaged 
the ratios based on integrated fluorescence intensities of original and digested 








For kinetic analysis of histone modifying enzymes, peptide-based substrates are 
typically used, which accounts for straightforward characterization of both substrates and 
products using HPLC, mass spectrometry, and other methods. However, these analytical 
methods are difficult to apply to histone and nucleosome-based substrates. Although 
Western blot can serve as an alternative analytical approach, accurate quantification based 
on antibody detection is relatively difficult. Western blot also involves multiple steps that 
are tedious. Inspired by the finding that some sirtuins are general deacylases that 
catalytically remove a number of acylation types, we previously demonstrated that a long 
chain terminal olefin-containing fatty acylation on a nucleosomal lysine in combination 
with an olefin-tetrazine cycloaddition reaction to fluorescently label a fatty acyl-
nucleosome allowed characterization of SIRT6-targeted histone deacylation in the 
nucleosome context.276 However, the reaction used in the SIRT6 study was kinetically 
slow, which required a long labeling time. To resolve this problem, we demonstrated the 
genetic encoding of AzHeK in the current study for the synthesis of azide-containing fatty 
acyl-nucleosomes that can be quickly labeled with a DBCO-based dye but still serve as 
substrates for SIRT7. Using this new click chemistry-based approach, we expediently 
characterized SIRT7-catalyzed deacylation on multiple acyl-nucleosome substrates. 
Given that SIRT1, SIRT2, SIRT6, and SIRT7 share similar catalytic features199 and some 
Zn2+-dependent HDACs are also active to remove long chain fatty acylation from histone 
lysines,282, 283 this newly developed method can potentially serve as an efficient tool to 
study all these enzymes.  
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   SIRT7 is a demonstrated histone H3 K18 deacetylase in cells. However, it 
doesn’t display appreciable activity when assayed on H3K18ac as a free histone H3 
protein. Our studies with 8 other acetyl-H3 histone substrates showed exactly same results. 
Apparently, SIRT7 is inactive toward a stand-alone acetyl-histone substrate. SIRT7 has an 
isoelectric point (pI) as 9.8. This high pI makes it highly positively charged at 
physiological pH. The calculated positive net charges determined by Protein Calculator 
v3.4 at pH 7.4 for SIRT7 are about 24. Histone H3 naturally has many lysine and arginine 
residues, which result in also a high pI value as 11.1. At pH 7.4, an acetyl-H3 will have 
positive net charges about 19. Since both SIRT7 and an acetyl-H3 substrate are highly 
positively charged at physiological pH, they will naturally have strong electrostatic 
repulsion that prevents their direct binding for deacetylation. This explains our in vitro 
data and also supports the notion that SIRT7 doesn’t natively deacetylate free histones in 
cells. We have also made a similar observation with SIRT6, a close homolog of SIRT7. 
Although SIRT6 actively removes acetylation from H3 K9 in cells,202 it is inactive toward 
an H3K9ac substrate. Like SIRT7, SIRT6 has a high pI value as 9.3 that makes it highly 
positively charged at physiological pH and consequently repel the binding of an acetyl-
H3 substrate. Although SIRT6 and SIRT7 naturally repel acetyl-histone substrates, their 
highly positively charged nature makes them easily associate electrostatically with 
negatively charged DNA in chromatin. As a matter of fact, both enzymes have been 
characterized as chromatin binding enzymes. In a chromatin setup, not only does 
chromosomal DNA neutralize positive charges in both SIRT6 or SIRT7 and an acetyl-
histone substrate for relieving their electrostatic repulsion, but it also serves as a mediator 
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to bring SIRT6 or SIRT7 and the acetyl-histone substrate into close proximity for 
deacetylation. As shown here for SIRT7 and previously for SIRT6, putting H3K18ac and 
H3K9ac in a nucleosome context brought up their significant deacetylation by SIRT7 and 
SIRT6, respectively. Therefore, both enzymes are nucleosome-dependent deacylases. 
DNA in chromatin may also serves to activate SIRT7. A previous report showed that free 
DNA activates SIRT7-catalyzed deacetylation of an acetyl-peptide substrate.268 We re-
evaluated this potential DNA activating effect using both an acyl-nucleosome substrate 
and an acyl-H3-H4 tetramer substrate. Providing free DNA clearly inhibited SIRT7-
catalyzed deacylation on the acyl-nucleosome substrate. However, adding a small amount 
of DNA to the acyl-H3/H4 tetramer substrate significantly improved its deacylation by 
SIRT7 at the beginning but this improvement was offset when additional DNA was added. 
These results support our conclusion that DNA serves only as a mediator to bring SIRT7 
and an acyl-histone substrate into close proximity for deacylation. Free DNA competes 
against an acyl-nucleosome substrate to bind SIRT7 and therefore inhibits SIRT7-
catalyzed deacylation of the acyl-nucleosome substrate. However, when DNA is provided 
in a small amount to an acyl-H3-H4 tetramer substrate, a single DNA fragment is able to 
bind both SIRT7 and the acyl-H3-H4 tetramer substrate to form a 1:1:1 complex and 
therefore serves to bring them to close proximity for interactions and deacylation. When 
provided in a large amount, additional DNA competes against the formation of a DNA-
SIRT7-substrate (1:1:1) complex that is required for deacylation and consequently brings 
down the SIRT7-catalyzed deacylation of the acyl-H3-H4 tetramer substrate. The 
interactions between DNA and SIRT7 are largely electrostatic in nature. When we 
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provided NaCl that disrupts electrostatic interactions, the activity of SIRT7 on an acyl-
nucleosome substrate was clearly inhibited. We further confirmed the electrostatic nature 
of DNA-SIRT7 interactions by appending an acyl-nucleosome substrate with two 
additional linker DNAs to show an improve deacylation activity by SIRT7. These linker 
DNAs do not directly participate in the nucleosome complex formation. Their negative 
charges are less neutralized like the wrapping DNA. With more net negative charges, they 
were expected to interact more efficiently with SIRT7 than the wrapping DNA for 
improving SIRT7 binding and recognition of the integrated acyl-histone substrate in the 
nucleosome context for deacylation. This was exactly what the results showed.  
   Our current SIRT7 study also points out a critical aspect of epigenetic enzymes 
that might have been long ignored in their biochemical analysis. Most histone modifying 
enzymes naturally interact directly or indirectly with chromatin in which nucleosome is 
the smallest subunit. It is logic to consider that corresponding nucleosome substrates might 
be minimally required to study these enzymes for resembling their catalytic features in 
cells. However, for convenient reasons, a lot of biochemical studies that have been carried 
out for histone modifying enzymes are based on peptide substrates and some are based on 
histones. How much an activity of a histone modifying enzyme on a peptide or histone 
substrate deviates from that of a nucleosome or chromatin substrate is a significant 
concern. Many histone modifying enzymes such as GCN5, MLL1-2, Suv39h1-2, 
Suv420h1-2, Dot1L, and KDM4D share the highly basic feature similar to SIRT6 and 
SIRT7, their strong interactions with chromatin for improved activities on histones are 
expected. There are also a large number of histone modifying enzymes that have strong 
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acidic features. Most Zn2+-dependent HDACs have relatively low pI values. At 
physiological pH, they are highly negatively charged and thus expected to bind tightly to 
histones but resist the association with chromatin. Although peptide substrate-based data 
have indicated strong deacetylation activities for most Zn2+-dependent HDACs,284 it is 
doubtful that these enzymes behave the same on nucleosome or chromatin substrates. 
Many Zn2+-dependent HDACs are part of transcription factor complexes that associate 
with chromatin. It is highly possible they are brought into interactions with their histone 
substrates within chromatin by their associated partners in these complexes to avoid 
electrostatic repulsion with chromatin DNA. Supported by the SIRT7 study in this work 
and our previous study with SIRT6, we strongly recommend re-characterizing 
biochemistry of most histone modifying enzymes using related nucleosome substrates.  
As for SIRT7-targetted H3 lysine sites, we were able to successfully confirm the 
previously discovered H3 K18 site but surprisingly revealed the H3 K36 site. SIRT7 
displays a several fold more activity to deacylate H3 K36 than to deacylate H3 K18. We 
did not observe appreciate activities on other tested H3 lysine sites. H3 K18 and H3 K36 
have both low peptide sequence resemblance and low chemical environment resemblance. 
How SIRT7 recognizes these two dissimilar lysine sites for deacylation is very intriguing. 
Interestingly, H3 K18 highly resembles H3 K9 and H3 K27 in peptide sequence contexts. 
All three lysines are in the H3 N-terminal tail with much lower structural constrain in 
comparison to H3 K36 that is at the DNA entry/exit site of the nucleosome dyad. Our 
previous study showed that SIRT6 was mainly active to deacylate these three H3 lysine 
sites probably due to their consensual sequence contexts.276 It is quite puzzling that SIRT7, 
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a close homolog of SIRT6, deacylates H3 K18 but is totally inert toward H3 K9 and H3 
K27. Given that H3 K36 is at the DNA entry/exit site of the nucleosome dyad, unwrapping 
DNA partially from the nucleosome core will be necessary to leave enough space for 
SIRT7 to bind and deacylate it. How SIRT7 unwraps DNA and then interacts with both 
DNA and H3 K36 is perplexing. Before the structure of SIRT7 complexed with an acyl-
nucleosome substrate is finally determined, we hesitate to postulate a theory to explain 
our observation.  
   H3K36ac is an active transcription mark that accumulates at the transcription 
start sites.231 It is enriched in euchromatin, which is possibly due to its potential weakening 
of the nucleosome complex.285 Our in vitro assembled nu’-H3K36ac did show more DNA 
unwrapping than the nucleosome without any acetylation. When we overexpressed SIRT7 
in cells, we did observe down-regulation of acetylation at both H3 K18 and H3 K36, 
confirming H3 K36 as a cellular deacetylation target of SIRT7. Importantly, we also 
showed that loss of SIRT7 in human cells leads to hyperacetylation of H3K36, which can 
be detected at the level of whole cell extracts, isolated nucleoli, and select SIRT7 target 
promoters. These findings demonstrate that endogenous SIRT7 has an essential function 
in determining the physiologic levels of this acetylation mark.  
   Our biochemical fractionation and ChIP studies also reveal the pivotal role of 
SIRT7 in maintaining low H3K36ac levels at rDNA in nucleoli. SIRT7 has two distinct 
functions at rDNA sequences, which exist in either active or silent chromatin states. At 
active rDNA, where SIRT7 was previously linked to rDNA transcriptional activation, 
SIRT7-dependent removal of H3K36ac might allow for maintenance of H3K36me3, 
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which is associated with transcription elongation.257 By contrast, at silent rDNA regions, 
H3 K36 deacetylation by SIRT7 might have a novel function in contributing to SIRT7 
effects on heterochromatin maintenance and prevention of rDNA instability.258 Finally, 
SIRT7 is recruited to DNA DSBs where it contributes to DNA damage responses.266 An 
intriguing possibility is that SIRT7-dependent deacetylation of H3 K36 at DSBs might 







CHAPTER IV  
CONCLUDING REMARKS AND FUTURE OUTLOOK 
 
In this study, we incorporated Nε-(7-octenoyl)-lysine (OcK) and NƐ-(7-
azidoheptanoyl)-L-lysine (AzHeK) into different lysine sites of Histone H3 (oc-H3), and 
assembled them into mono-nucleosome substrates. Since SIRT6 and SIRT7 have been 
reported as nucleosome-dependent Histone deacylases, we screened site-specificity of 
these two enzymes against nucleosomes with OcK or AzHeK at different lysine sites. 
Acylation level changes during SIRT6 or SIRT7 incubation were detected through the 
click reaction either between pyrimidine-tetrazine conjugated FITC and OcK, or 
between dibenzocyclooctyne conjugated MB488 and AzHeK.  
For SIRT6, besides confirming the previously reported H3 K9 acylation, we 
discovered several other active sites. Overall, the amino acid in front of lysine appears to 
determine the deacylation activity. For sites with higher activity, H3 K18, H3 K27 and 
the previously reported H3 K9 all have arginine at the -1 position. H3 K4 and H3 K23 
demonstrate relatively weaker activity and they have threonine at the -1 position. 
However, only H3 K9, H3 K18 and H3 K27 were confirmed as SIRT6 targets in 
HEK293t cell. For SIRT7, we confirmed the previously reported site H3 K18 and 
discovered another much more active site H3 K36, which was validated as the in vivo 
target in both SIRT7 overexpressed and SIRT7 knockdown mammalian cell models. 
SIRT7 was further demonstrated as loci-specifc H3 K36 deacetylase at gene promoters, 
nucleoli and telomeres. We also revealed that DNA acted as the negatively charged 
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‘bridge’ bringing positively charged histone and SIRT7 into proximity through 
electrostatic interactions, thus extranucleosomal DNA activated SIRT7 deacylation by 
acting as the additional negatively charged binding surface. 
 Histone PTM code is a complex system managing the thousands of genes. To 
understand the independent and combinatorial meaning of all PTM, one fundamental 
task would be revealing the accurate site-specificity of PTM editing and reading 
proteins. Our results indicated the necessity of characterizing epigenetic enzymes’ site-
specificity using the native nucleosome substrates, as many of these enzymes show 
distinct in vitro reactivity between peptide, histone and nucleosomes. Most histone PTM 
sites are blocked by the wrapping DNA, which requires either the enzymes to have 
intrinsic DNA binding affinity such as SIRT6 or SIRT7, or other co-activators such as 
CoREST to facilitate binding between enzymes and nucleosomes. Recently, many 
epigenetic enzymes were found to be regulated by the existing PTM on the substrate. 
And characterization of this PTM crosstalk effect is clearly expected to be only correct if 
nucleosomes are used as in vitro substrates, since the space-distribution of histone tails 
and allosteric effect of other nucleosome components such as DNA must be considered. 
The biggest obstacle for nucleosome biochemical study is the reconstitution of 
homogenous nucleosome substrates with site-specific PTM. With the rapid development 
of histone synthesis techniques such as non-canonical amino acid incorporation, 
expressed protein ligation and bio-orthogonal reaction, more precise details of epigenetic 
code will be revealed in the future. 
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